Data Pkg 7 Specialty Drug Utilization, Retail and Mail.xlsx
XLSX spreadsheet 94 KB Posted
- Attached to
- DRAFT RFP TRICARE Pharmacy Services, 5th Generation (TPharm5) Federal contract opportunity
- Solicitation number
- HT940220R0002
- Issued by
- Defense Health Agency
About this file
This draft request for proposals from the Defense Health Agency seeks pharmacy services for the TRICARE Pharmacy Program, 5th Generation. The anticipated contract would have an 18-month base period for transition, seven 1-year option periods for healthcare delivery, and potential 6-month extension. The Defense Health Agency is requesting industry feedback on sections of the draft RFP related to statements of objectives, specialty pharmacy, retail network access, compounded medications, care coordination, patient safety notifications, and quality control. Interested parties should submit any questions or comments on the draft RFP by January 17, 2020. The Defense Health Agency estimates issuing a formal solicitation in mid-2020.
View the file
Other files for this federal contract opportunity
Show all 50
DRAFT RFP TRICARE Pharmacy Services, 5th Generation (TPharm5) has more files on GovTribe.
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Specialty Drugs 2017
| FOR OFFICIAL USE ONLY | ||||||||||||||||||||||||||
| Title: Retail & Mail Order Specialty Drug RX Volume | ||||||||||||||||||||||||||
| Date Range: 1/1/2017 - 12/31/2017 | ||||||||||||||||||||||||||
| Jan-17 | Feb-17 | Mar-17 | Apr-17 | May-17 | Jun-17 | Jul-17 | Aug-17 | Sep-17 | Oct-17 | Nov-17 | Dec-17 | Grand Total | ||||||||||||||
| # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | ||
| Drug/Strength/Form | Brand/Generic Indicator | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | |
| abatacept 125 MG/ML AUTO INJCT | Brand Single Source | 43 | 12 | 58 | 11 | 52 | 11 | 65 | 8 | 77 | 14 | 85 | 6 | 94 | 13 | 86 | 8 | 110 | 8 | 119 | 8 | 144 | 15 | 133 | 13 | 1,193 |
| abatacept 125 MG/ML SYRINGE | Brand Single Source | 294 | 37 | 231 | 39 | 277 | 48 | 244 | 41 | 285 | 49 | 256 | 41 | 254 | 50 | 276 | 45 | 213 | 45 | 263 | 50 | 217 | 50 | 233 | 39 | 3,577 |
| abatacept 87.5MG/0.7 SYRINGE | Brand Single Source | 1 | 1 | 1 | 3 | |||||||||||||||||||||
| adalimumab 10MG/0.2ML SYRINGEKIT | Brand Single Source | 3 | 2 | 2 | 3 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 19 | |||||||||||||
| adalimumab 20MG/0.4ML SYRINGEKIT | Brand Single Source | 22 | 2 | 26 | 1 | 33 | 28 | 1 | 25 | 1 | 37 | 1 | 31 | 27 | 26 | 17 | 23 | 1 | 34 | 336 | ||||||
| adalimumab 40MG/0.8ML PEN IJ KIT | Brand Single Source | 3,466 | 435 | 3,125 | 428 | 3,518 | 497 | 3,295 | 441 | 3,566 | 503 | 3,549 | 474 | 3,473 | 445 | 3,742 | 495 | 3,210 | 447 | 3,567 | 460 | 3,444 | 426 | 3,362 | 397 | 46,765 |
| adalimumab 40MG/0.8ML SYRINGEKIT | Brand Single Source | 678 | 110 | 526 | 110 | 683 | 107 | 601 | 110 | 678 | 108 | 617 | 99 | 620 | 90 | 668 | 96 | 569 | 100 | 605 | 97 | 619 | 94 | 607 | 98 | 8,690 |
| anakinra 100MG/0.67 SYRINGE | Brand Single Source | 26 | 4 | 15 | 4 | 18 | 2 | 19 | 4 | 17 | 4 | 23 | 6 | 17 | 5 | 18 | 5 | 24 | 4 | 16 | 2 | 16 | 4 | 22 | 2 | 277 |
| antihemophil.FVIII,full length 1000 (+/-) VIAL | Brand Originator | 11 | 15 | 19 | 16 | 19 | 16 | 19 | 17 | 15 | 15 | 17 | 14 | 193 | ||||||||||||
| antihemophil.FVIII,full length 1500 (+/-) VIAL | Brand Single Source | 9 | 11 | 9 | 9 | 8 | 11 | 6 | 10 | 6 | 5 | 5 | 5 | 94 | ||||||||||||
| antihemophil.FVIII,full length 2000 (+/-) VIAL | Brand Originator | 8 | 14 | 13 | 18 | 15 | 16 | 15 | 17 | 20 | 20 | 21 | 19 | 196 | ||||||||||||
| antihemophil.FVIII,full length 250 (+/-) VIAL | Brand Originator | 10 | 11 | 11 | 10 | 13 | 11 | 6 | 8 | 11 | 13 | 4 | 9 | 117 | ||||||||||||
| antihemophil.FVIII,full length 3000 (+/-) VIAL | Brand Originator | 17 | 17 | 16 | 17 | 16 | 18 | 16 | 11 | 9 | 9 | 17 | 11 | 174 | ||||||||||||
| antihemophil.FVIII,full length 4000 (+/-) VIAL | Brand Single Source | 2 | 5 | 3 | 1 | 3 | 1 | 15 | ||||||||||||||||||
| antihemophil.FVIII,full length 500 (+/-) VIAL | Brand Originator | 35 | 18 | 20 | 20 | 27 | 20 | 20 | 27 | 20 | 22 | 22 | 24 | 275 | ||||||||||||
| antihemophilic factor, hum rec 1000 (+/-) VIAL | Brand Single Source | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 10 | ||||||||||||||||
| antihemophilic factor, hum rec 1500 (+/-) VIAL | Brand Single Source | 2 | 3 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | 4 | 3 | 1 | 27 | ||||||||||||
| antihemophilic factor, hum rec 2000 (+/-) VIAL | Brand Single Source | 2 | 2 | 3 | 3 | 2 | 3 | 4 | 4 | 3 | 5 | 3 | 2 | 36 | ||||||||||||
| antihemophilic factor, hum rec 250 (+/-) VIAL | Brand Single Source | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 10 | ||||||||||||||||
| antihemophilic factor, hum rec 500 (+/-) VIAL | Brand Single Source | 1 | 1 | 3 | 1 | 1 | 1 | 8 | ||||||||||||||||||
| antihemophilic factor, human 1000 (+/-) VIAL | Brand Originator | 1 | 1 | |||||||||||||||||||||||
| antihemophilic factor, human 1000 (+/-) VIAL | Brand Single Source | 2 | 2 | 1 | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 1 | 18 | |||||||||||||
| antihemophilic factor, human 250 (+/-) VIAL | Brand Single Source | 1 | 1 | 1 | 1 | 1 | 5 | |||||||||||||||||||
| antihemophilic factor, human 500 (+/-) VIAL | Brand Single Source | 1 | 1 | 1 | 2 | 5 | ||||||||||||||||||||
| antihemophilic factor/VWF 1000 (400) VIAL | Brand Single Source | 4 | 3 | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 4 | 2 | 24 | |||||||||||||
| antihemophilic factor/VWF 1000-2400 VIAL | Brand Single Source | 3 | 6 | 3 | 7 | 7 | 6 | 6 | 7 | 3 | 4 | 5 | 7 | 64 | ||||||||||||
| antihemophilic factor/VWF 1500 (600) VIAL | Brand Single Source | 2 | 1 | 4 | 4 | 1 | 1 | 1 | 2 | 4 | 20 | |||||||||||||||
| antihemophilic factor/VWF 1K-1K UNIT VIAL | Brand Single Source | 4 | 6 | 7 | 6 | 6 | 5 | 4 | 7 | 5 | 4 | 5 | 6 | 65 | ||||||||||||
| antihemophilic factor/VWF 2000 (800) VIAL | Brand Single Source | 3 | 7 | 2 | 6 | 5 | 4 | 4 | 3 | 3 | 4 | 4 | 5 | 50 | ||||||||||||
| antihemophilic factor/VWF 250 (100) VIAL | Brand Single Source | 3 | 3 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 19 | |||||||||||||
| antihemophilic factor/VWF 250-600 VIAL | Brand Single Source | 3 | 4 | 1 | 2 | 1 | 2 | 2 | 2 | 1 | 1 | 19 | ||||||||||||||
| antihemophilic factor/VWF 500 (200) VIAL | Brand Single Source | 4 | 4 | 2 | 1 | 3 | 5 | 2 | 3 | 2 | 1 | 2 | 4 | 33 | ||||||||||||
| antihemophilic factor/VWF 500-1200 VIAL | Brand Single Source | 6 | 4 | 3 | 2 | 5 | 1 | 2 | 5 | 5 | 2 | 3 | 3 | 41 | ||||||||||||
| antihemophilic factor/VWF 500-500 VIAL | Brand Single Source | 1 | 2 | 3 | ||||||||||||||||||||||
| apremilast 10-20-30MG TAB DS PK | Brand Single Source | 17 | 13 | 14 | 12 | 14 | 19 | 13 | 13 | 16 | 12 | 14 | 8 | 19 | 6 | 13 | 12 | 9 | 7 | 12 | 15 | 8 | 12 | 12 | 13 | 303 |
| apremilast 30 MG TABLET | Brand Single Source | 755 | 117 | 643 | 115 | 743 | 154 | 706 | 128 | 774 | 141 | 756 | 116 | 781 | 111 | 767 | 134 | 656 | 113 | 780 | 122 | 689 | 115 | 737 | 107 | 10,260 |
| axitinib 1 MG TABLET | Brand Single Source | 4 | 3 | 6 | 6 | 6 | 5 | 4 | 5 | 3 | 4 | 8 | 1 | 11 | 1 | 9 | 8 | 1 | 10 | 1 | 5 | 3 | 104 | |||
| axitinib 5 MG TABLET | Brand Single Source | 5 | 11 | 8 | 7 | 10 | 9 | 7 | 11 | 7 | 11 | 12 | 2 | 14 | 5 | 14 | 5 | 13 | 4 | 14 | 5 | 11 | 3 | 14 | 1 | 203 |
| bexarotene 1 % GEL (GRAM) | Brand Single Source | 4 | 5 | 1 | 3 | 3 | 4 | 2 | 5 | 1 | 4 | 1 | 3 | 4 | 3 | 4 | 1 | 4 | 52 | |||||||
| bexarotene 75 MG CAPSULE | Brand Originator | 12 | 6 | 11 | 9 | 1 | 11 | 10 | 9 | 18 | 3 | 10 | 14 | 13 | 127 | |||||||||||
| bexarotene 75 MG CAPSULE | Generic | 7 | 6 | 7 | 6 | 5 | 6 | 4 | 2 | 4 | 4 | 2 | 3 | 56 | ||||||||||||
| bosentan 125 MG TABLET | Brand Originator | 116 | 108 | 120 | 104 | 121 | 113 | 108 | 114 | 106 | 107 | 98 | 104 | 1,319 | ||||||||||||
| bosentan 32 MG TAB SUSP | Brand Single Source | 1 | 1 | 2 | ||||||||||||||||||||||
| bosentan 62.5 MG TABLET | Brand Originator | 24 | 17 | 22 | 18 | 21 | 17 | 21 | 24 | 16 | 21 | 22 | 15 | 238 | ||||||||||||
| certolizumab pegol 400 MG KIT | Brand Single Source | 7 | 6 | 1 | 5 | 9 | 6 | 5 | 5 | 7 | 6 | 1 | 4 | 2 | 9 | 5 | 78 | |||||||||
| certolizumab pegol 400MG/2ML SYRINGEKIT | Brand Single Source | 251 | 38 | 247 | 37 | 259 | 43 | 230 | 34 | 275 | 32 | 235 | 32 | 246 | 35 | 243 | 30 | 236 | 30 | 228 | 31 | 226 | 16 | 220 | 29 | 3,283 |
| coagulation factor VIIa,recomb 1 MG VIAL | Brand Single Source | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 13 | |||||||||||||||
| coagulation factor VIIa,recomb 2 MG VIAL | Brand Single Source | 2 | 9 | 3 | 2 | 2 | 1 | 2 | 3 | 4 | 2 | 1 | 2 | 33 | ||||||||||||
| coagulation factor VIIa,recomb 5 MG VIAL | Brand Single Source | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 3 | 2 | 7 | 23 | ||||||||||||||
| coagulation factor VIIa,recomb 8 MG VIAL | Brand Single Source | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 | ||||||||||||||||
| darbepoetin alfa in polysorbat 100 MCG/ML VIAL | Brand Single Source | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 5 | 1 | 2 | 2 | 3 | 3 | 3 | 1 | 2 | 3 | 2 | 2 | 3 | 1 | 45 | |||
| darbepoetin alfa in polysorbat 100MCG/0.5 SYRINGE | Brand Single Source | 14 | 8 | 9 | 1 | 9 | 1 | 11 | 2 | 9 | 3 | 10 | 4 | 12 | 2 | 4 | 1 | 4 | 3 | 8 | 4 | 8 | 5 | 4 | 3 | 139 |
| darbepoetin alfa in polysorbat 150MCG/0.3 SYRINGE | Brand Single Source | 1 | 1 | 3 | 2 | 1 | 2 | 1 | 3 | 2 | 2 | 5 | 3 | 5 | 2 | 3 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 47 | ||
| darbepoetin alfa in polysorbat 200 MCG/ML VIAL | Brand Single Source | 1 | 2 | 1 | 2 | 2 | 5 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 2 | 1 | 29 | ||||||
| darbepoetin alfa in polysorbat 200MCG/0.4 SYRINGE | Brand Single Source | 9 | 5 | 6 | 3 | 7 | 5 | 4 | 6 | 6 | 2 | 6 | 3 | 10 | 4 | 10 | 4 | 4 | 2 | 9 | 2 | 7 | 3 | 3 | 1 | 121 |
| darbepoetin alfa in polysorbat 25 MCG/ML VIAL | Brand Single Source | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 3 | 2 | 1 | 2 | 2 | 2 | 21 | |||||||||||
| darbepoetin alfa in polysorbat 25MCG/0.42 SYRINGE | Brand Single Source | 3 | 4 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 5 | 2 | 4 | 4 | 3 | 5 | 1 | 3 | 5 | 55 | |||
| darbepoetin alfa in polysorbat 300 MCG/ML VIAL | Brand Single Source | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 10 | |||||||||||||||
| darbepoetin alfa in polysorbat 300MCG/0.6 SYRINGE | Brand Single Source | 3 | 5 | 2 | 3 | 4 | 2 | 2 | 4 | 4 | 4 | 2 | 3 | 3 | 2 | 2 | 4 | 2 | 2 | 3 | 3 | 1 | 3 | 6 | 4 | 73 |
| darbepoetin alfa in polysorbat 40 MCG/0.4 SYRINGE | Brand Single Source | 6 | 5 | 3 | 6 | 3 | 6 | 5 | 9 | 5 | 2 | 3 | 2 | 2 | 5 | 1 | 4 | 7 | 4 | 3 | 6 | 4 | 3 | 6 | 3 | 103 |
| darbepoetin alfa in polysorbat 40 MCG/ML VIAL | Brand Single Source | 2 | 1 | 1 | 2 | 1 | 4 | 4 | 5 | 3 | 2 | 1 | 1 | 4 | 1 | 1 | 33 | |||||||||
| darbepoetin alfa in polysorbat 500 MCG/ML SYRINGE | Brand Single Source | 2 | 3 | 3 | 1 | 5 | 2 | 3 | 1 | 1 | 3 | 3 | 1 | 2 | 1 | 31 | ||||||||||
| darbepoetin alfa in polysorbat 60 MCG/0.3 SYRINGE | Brand Single Source | 16 | 7 | 12 | 5 | 8 | 6 | 6 | 4 | 11 | 3 | 6 | 5 | 9 | 4 | 7 | 8 | 6 | 1 | 9 | 6 | 5 | 3 | 7 | 4 | 158 |
| darbepoetin alfa in polysorbat 60 MCG/ML VIAL | Brand Single Source | 1 | 1 | 2 | 1 | 4 | 1 | 3 | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 3 | 1 | 27 | |||||||
| dasatinib 100 MG TABLET | Brand Single Source | 100 | 15 | 103 | 18 | 100 | 16 | 90 | 18 | 102 | 14 | 92 | 14 | 95 | 13 | 94 | 14 | 108 | 12 | 99 | 13 | 98 | 13 | 90 | 19 | 1,350 |
| dasatinib 140 MG TABLET | Brand Single Source | 7 | 5 | 5 | 1 | 2 | 2 | 9 | 6 | 3 | 1 | 7 | 2 | 4 | 2 | 6 | 1 | 6 | 3 | 1 | 2 | 1 | 76 | |||
| dasatinib 20 MG TABLET | Brand Single Source | 16 | 1 | 12 | 15 | 1 | 15 | 17 | 16 | 9 | 18 | 17 | 16 | 1 | 15 | 1 | 14 | 1 | 185 | |||||||
| dasatinib 50 MG TABLET | Brand Single Source | 33 | 3 | 33 | 3 | 31 | 3 | 28 | 3 | 30 | 1 | 28 | 1 | 31 | 1 | 36 | 3 | 30 | 2 | 31 | 1 | 32 | 4 | 37 | 4 | 409 |
| dasatinib 70 MG TABLET | Brand Single Source | 11 | 5 | 10 | 3 | 15 | 7 | 15 | 5 | 15 | 8 | 13 | 6 | 13 | 7 | 9 | 7 | 17 | 4 | 14 | 4 | 10 | 4 | 16 | 6 | 224 |
| dasatinib 80 MG TABLET | Brand Single Source | 10 | 5 | 4 | 5 | 7 | 2 | 11 | 2 | 14 | 3 | 10 | 9 | 2 | 12 | 3 | 12 | 2 | 14 | 1 | 11 | 5 | 13 | 2 | 159 | |
| deferasirox 125 MG TAB DISPER | Brand Originator | 3 | 5 | 1 | 3 | 1 | 3 | 1 | 3 | 3 | 2 | 3 | 2 | 4 | 1 | 2 | 2 | 3 | 1 | 43 | ||||||
| deferasirox 250 MG TAB DISPER | Brand Originator | 3 | 1 | 1 | 1 | 4 | 7 | 4 | 2 | 4 | 3 | 4 | 2 | 2 | 2 | 2 | 42 | |||||||||
| deferasirox 500 MG TAB DISPER | Brand Originator | 15 | 3 | 14 | 4 | 6 | 3 | 1 | 11 | 1 | 6 | 17 | 2 | 18 | 3 | 12 | 2 | 9 | 1 | 7 | 2 | 8 | 1 | 146 | ||
| desmopressin (nonrefrigerated) 10/SPRAY SPRAY/PUMP | Brand Originator | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 19 | |||||||||
| desmopressin (nonrefrigerated) 10/SPRAY SPRAY/PUMP | Generic | 45 | 33 | 50 | 51 | 40 | 50 | 53 | 50 | 45 | 47 | 49 | 46 | 45 | 42 | 51 | 38 | 44 | 44 | 55 | 39 | 53 | 42 | 47 | 32 | 1,091 |
| desmopressin acetate 0.1 MG/ML SOLUTION | Brand Single Source | 1 | 2 | 1 | 2 | 2 | 2 | 1 | 3 | 1 | 2 | 3 | 1 | 1 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 32 | ||||
| desmopressin acetate 10/SPRAY SPRAY/PUMP | Generic | 2 | 38 | 32 | 37 | 31 | 30 | 23 | 28 | 25 | 27 | 26 | 25 | 27 | 351 | |||||||||||
| desmopressin acetate 150/SPRAY SPRAY/PUMP | Brand Single Source | 10 | 10 | 8 | 9 | 5 | 11 | 11 | 7 | 6 | 5 | 5 | 13 | 7 | 11 | 13 | 20 | 4 | 7 | 7 | 6 | 8 | 6 | 6 | 11 | 206 |
| desmopressin acetate 4 MCG/ML AMPUL | Generic | 1 | 1 | 2 | ||||||||||||||||||||||
| desmopressin acetate 4 MCG/ML VIAL | Brand Originator | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 18 | |||||||||||
| desmopressin acetate 4 MCG/ML VIAL | Generic | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 9 | ||||||||||||||||
| dimethyl fumarate 120 MG CAPSULE DR | Brand Single Source | 8 | 1 | 7 | 5 | 6 | 1 | 4 | 2 | 6 | 4 | 10 | 6 | 7 | 4 | 9 | 80 | |||||||||
| dimethyl fumarate 120-240 MG CAPSULE DR | Brand Single Source | 12 | 1 | 21 | 1 | 23 | 14 | 2 | 23 | 11 | 2 | 12 | 1 | 9 | 1 | 15 | 11 | 25 | 2 | 14 | 1 | 201 | ||||
| dimethyl fumarate 240 MG CAPSULE DR | Brand Single Source | 358 | 142 | 304 | 129 | 329 | 143 | 326 | 119 | 346 | 127 | 314 | 113 | 327 | 101 | 302 | 107 | 283 | 104 | 306 | 104 | 300 | 98 | 280 | 80 | 5,142 |
| epoetin alfa 10000/ML VIAL | Brand Originator | 42 | 52 | 34 | 51 | 46 | 59 | 37 | 59 | 44 | 51 | 50 | 43 | 40 | 53 | 46 | 51 | 43 | 54 | 43 | 47 | 36 | 37 | 42 | 42 | 1,102 |
| epoetin alfa 2000/ML VIAL | Brand Originator | 1 | 10 | 2 | 1 | 2 | 2 | 1 | 2 | 1 | 3 | 2 | 6 | 2 | 5 | 6 | 7 | 3 | 2 | 4 | 3 | 5 | 2 | 4 | 4 | 80 |
| epoetin alfa 20000/2ML VIAL | Brand Originator | 3 | 5 | 1 | 4 | 5 | 8 | 2 | 2 | 3 | 2 | 3 | 2 | 2 | 2 | 1 | 6 | 2 | 2 | 2 | 2 | 5 | 2 | 3 | 69 | |
| epoetin alfa 20000/ML VIAL | Brand Originator | 49 | 42 | 42 | 47 | 52 | 57 | 40 | 46 | 50 | 56 | 48 | 39 | 38 | 36 | 48 | 40 | 37 | 37 | 52 | 39 | 39 | 40 | 33 | 39 | 1,046 |
| epoetin alfa 3000/ML VIAL | Brand Originator | 1 | 9 | 1 | 5 | 1 | 1 | 1 | 4 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 38 | ||||
| epoetin alfa 4000/ML VIAL | Brand Originator | 8 | 12 | 7 | 7 | 5 | 5 | 9 | 4 | 6 | 3 | 6 | 5 | 6 | 6 | 9 | 4 | 4 | 10 | 4 | 8 | 7 | 9 | 4 | 8 | 156 |
| epoetin alfa 40000/ML VIAL | Brand Single Source | 45 | 33 | 34 | 27 | 39 | 30 | 34 | 38 | 38 | 39 | 45 | 33 | 50 | 31 | 36 | 41 | 44 | 52 | 46 | 36 | 50 | 48 | 34 | 34 | 937 |
| etanercept 25 MG VIAL | Brand Single Source | 80 | 15 | 69 | 11 | 71 | 14 | 66 | 11 | 77 | 21 | 72 | 16 | 72 | 12 | 78 | 10 | 69 | 8 | 65 | 11 | 80 | 10 | 73 | 15 | 1,026 |
| etanercept 25MG/0.5ML SYRINGE | Brand Single Source | 76 | 12 | 59 | 13 | 60 | 12 | 55 | 10 | 65 | 13 | 55 | 13 | 57 | 9 | 68 | 10 | 54 | 10 | 60 | 11 | 53 | 11 | 46 | 12 | 844 |
| etanercept 50MG/ML(1) CARTRIDGE | Brand Single Source | 2 | 4 | 6 | ||||||||||||||||||||||
| etanercept 50MG/ML(1) PEN INJCTR | Brand Single Source | 1,273 | 169 | 1,105 | 154 | 1,275 | 170 | 1,087 | 156 | 1,250 | 168 | 1,134 | 156 | 1,169 | 143 | 1,133 | 127 | 1,075 | 118 | 1,160 | 144 | 1,104 | 115 | 1,024 | 121 | 15,530 |
| etanercept 50MG/ML(1) SYRINGE | Brand Single Source | 490 | 58 | 373 | 62 | 432 | 65 | 384 | 56 | 479 | 65 | 416 | 61 | 418 | 42 | 421 | 56 | 349 | 39 | 393 | 46 | 394 | 35 | 363 | 37 | 5,534 |
| everolimus 10 MG TABLET | Brand Single Source | 35 | 47 | 26 | 52 | 35 | 47 | 41 | 49 | 35 | 50 | 62 | 24 | 60 | 18 | 64 | 20 | 66 | 16 | 55 | 19 | 54 | 22 | 52 | 22 | 971 |
| everolimus 2 MG TAB SUSP | Brand Single Source | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 22 | |||||
| everolimus 2.5 MG TABLET | Brand Single Source | 3 | 1 | 1 | 1 | 3 | 2 | 6 | 2 | 4 | 2 | 1 | 3 | 6 | 3 | 3 | 1 | 3 | 4 | 2 | 1 | 4 | 3 | 2 | 4 | 65 |
| everolimus 3 MG TAB SUSP | Brand Single Source | 1 | 1 | 1 | 2 | 1 | 1 | 7 | ||||||||||||||||||
| everolimus 5 MG TAB SUSP | Brand Single Source | 1 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 21 | ||||||||
| everolimus 5 MG TABLET | Brand Single Source | 21 | 37 | 22 | 33 | 14 | 32 | 18 | 34 | 22 | 31 | 33 | 17 | 44 | 5 | 44 | 9 | 34 | 9 | 47 | 10 | 33 | 8 | 29 | 5 | 591 |
| everolimus 7.5 MG TABLET | Brand Single Source | 7 | 11 | 7 | 12 | 11 | 15 | 6 | 10 | 6 | 10 | 15 | 8 | 17 | 5 | 17 | 4 | 13 | 3 | 12 | 5 | 15 | 3 | 12 | 3 | 227 |
| factor IX 1000 (+/-) VIAL | Brand Originator | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 10 | |||||||||||||||
| factor IX 1500 (+/-) VIAL | Brand Single Source | 1 | 1 | 1 | 1 | 1 | 5 | |||||||||||||||||||
| factor IX 500 (+/-) VIAL | Brand Single Source | 1 | 1 | 2 | ||||||||||||||||||||||
| factor IX human recombinant 1000 UNIT VIAL | Brand Originator | 4 | 1 | 2 | 2 | 5 | 1 | 2 | 1 | 1 | 19 | |||||||||||||||
| factor IX human recombinant 2000 UNIT VIAL | Brand Originator | 2 | 3 | 4 | 1 | 3 | 4 | 5 | 5 | 2 | 2 | 3 | 2 | 36 | ||||||||||||
| factor IX human recombinant 250 UNIT VIAL | Brand Originator | 1 | 1 | 1 | 1 | 2 | 6 | |||||||||||||||||||
| factor IX human recombinant 3000 UNIT VIAL | Brand Originator | 2 | 2 | 5 | 2 | 2 | 4 | 5 | 3 | 1 | 4 | 3 | 4 | 37 | ||||||||||||
| factor IX human recombinant 500 UNIT VIAL | Brand Originator | 1 | 2 | 2 | 2 | 7 | ||||||||||||||||||||
| factor XIII 1000-1600 VIAL | Brand Single Source | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 2 | 1 | 1 | 2 | 1 | 16 | ||||||||||||
| filgrastim 300 MCG/ML VIAL | Brand Single Source | 8 | 13 | 9 | 16 | 4 | 18 | 10 | 5 | 9 | 15 | 7 | 16 | 13 | 13 | 10 | 12 | 13 | 11 | 14 | 12 | 15 | 10 | 7 | 11 | 271 |
| filgrastim 300MCG/0.5 SYRINGE | Brand Single Source | 15 | 18 | 10 | 22 | 21 | 12 | 10 | 21 | 11 | 21 | 16 | 15 | 11 | 16 | 15 | 27 | 5 | 15 | 10 | 20 | 11 | 26 | 5 | 23 | 376 |
| filgrastim 480MCG/0.8 SYRINGE | Brand Single Source | 14 | 22 | 7 | 12 | 6 | 17 | 10 | 18 | 11 | 13 | 25 | 11 | 6 | 13 | 11 | 10 | 13 | 9 | 12 | 9 | 15 | 6 | 9 | 16 | 295 |
| filgrastim 480MCG/1.6 VIAL | Brand Single Source | 1 | 1 | 5 | 3 | 2 | 1 | 2 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 1 | 34 | |||||
| fingolimod HCl 0.5 MG CAPSULE | Brand Single Source | 252 | 33 | 245 | 38 | 238 | 42 | 247 | 33 | 257 | 34 | 238 | 33 | 245 | 28 | 245 | 41 | 221 | 30 | 229 | 33 | 242 | 35 | 202 | 28 | 3,269 |
| glatiramer acetate 20 MG/ML SYRINGE | Brand Originator | 4 | 8 | 6 | 8 | 6 | 5 | 4 | 2 | 8 | 6 | 8 | 6 | 1 | 3 | 6 | 3 | 10 | 4 | 1 | 2 | 4 | 3 | 7 | 5 | 120 |
| glatiramer acetate 20 MG/ML SYRINGE | Generic | 52 | 23 | 49 | 23 | 58 | 28 | 42 | 18 | 58 | 20 | 47 | 22 | 46 | 26 | 56 | 16 | 45 | 19 | 45 | 20 | 42 | 17 | 47 | 17 | 836 |
| glatiramer acetate 40 MG/ML SYRINGE | Brand Originator | 342 | 67 | 335 | 68 | 378 | 63 | 289 | 56 | 408 | 60 | 336 | 66 | 331 | 68 | 363 | 60 | 310 | 43 | 327 | 38 | 343 | 23 | 296 | 22 | 4,692 |
| glatiramer acetate 40 MG/ML SYRINGE | Generic | 4 | 12 | 16 | 32 | |||||||||||||||||||||
| golimumab 100 MG/ML PEN INJCTR | Brand Single Source | 39 | 3 | 31 | 1 | 43 | 1 | 39 | 36 | 2 | 32 | 29 | 34 | 31 | 37 | 2 | 33 | 38 | 2 | 433 | ||||||
| golimumab 100 MG/ML SYRINGE | Brand Single Source | 3 | 1 | 1 | 3 | 2 | 2 | 1 | 5 | 3 | 4 | 3 | 2 | 4 | 2 | 1 | 1 | 1 | 39 | |||||||
| golimumab 50MG/0.5ML PEN INJCTR | Brand Single Source | 167 | 18 | 160 | 20 | 190 | 13 | 153 | 13 | 160 | 18 | 176 | 14 | 170 | 13 | 166 | 9 | 149 | 12 | 166 | 13 | 168 | 10 | 141 | 9 | 2,128 |
| golimumab 50MG/0.5ML SYRINGE | Brand Single Source | 28 | 1 | 26 | 6 | 27 | 5 | 22 | 6 | 18 | 8 | 26 | 5 | 26 | 8 | 22 | 4 | 27 | 4 | 20 | 3 | 19 | 4 | 25 | 4 | 344 |
| imatinib mesylate 100 MG TABLET | Brand Originator | 124 | 3 | 93 | 3 | 120 | 2 | 105 | 1 | 107 | 2 | 77 | 2 | 4 | 2 | 5 | 1 | 4 | 1 | 6 | 2 | 2 | 1 | 7 | 1 | 675 |
| imatinib mesylate 100 MG TABLET | Generic | 39 | 1 | 45 | 1 | 44 | 42 | 1 | 44 | 43 | 36 | 112 | 32 | 103 | 36 | 102 | 30 | 108 | 28 | 107 | 28 | 101 | 27 | 1,110 | ||
| imatinib mesylate 400 MG TABLET | Brand Originator | 335 | 11 | 281 | 8 | 279 | 9 | 152 | 8 | 19 | 4 | 14 | 6 | 18 | 7 | 16 | 9 | 15 | 9 | 15 | 7 | 12 | 5 | 13 | 7 | 1,259 |
| imatinib mesylate 400 MG TABLET | Generic | 69 | 79 | 86 | 157 | 89 | 267 | 103 | 335 | 72 | 286 | 68 | 339 | 75 | 294 | 67 | 315 | 77 | 321 | 65 | 318 | 68 | 3,550 | |||
| interferon alfa-2b,recomb. 10MM UNIT VIAL | Brand Single Source | 1 | 1 | 1 | 5 | 3 | 1 | 3 | 1 | 2 | 18 | |||||||||||||||
| interferon alfa-2b,recomb. 10MM/ML VIAL | Brand Single Source | 2 | 6 | 1 | 1 | 2 | 2 | 5 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 32 | |||||||
| interferon alfa-2b,recomb. 18MM UNIT VIAL | Brand Single Source | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 13 | |||||||||||||
| interferon alfa-2b,recomb. 50MM UNIT VIAL | Brand Single Source | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 9 | |||||||||||||||||
| interferon alfa-2b,recomb. 6MMUNIT/ML VIAL | Brand Single Source | 7 | 1 | 5 | 5 | 2 | 4 | 3 | 3 | 6 | 5 | 3 | 4 | 4 | 2 | 2 | 2 | 1 | 2 | 3 | 3 | 3 | 3 | 1 | 2 | 76 |
| interferon beta-1a 30MCG/.5ML PEN IJ KIT | Brand Single Source | 106 | 17 | 72 | 13 | 104 | 22 | 83 | 18 | 92 | 15 | 78 | 13 | 81 | 15 | 90 | 14 | 75 | 15 | 75 | 12 | 78 | 13 | 71 | 14 | 1,186 |
| interferon beta-1a 30MCG/.5ML SYRINGEKIT | Brand Single Source | 84 | 23 | 73 | 15 | 82 | 23 | 71 | 14 | 77 | 23 | 68 | 15 | 68 | 10 | 66 | 12 | 68 | 10 | 63 | 12 | 69 | 11 | 59 | 11 | 1,027 |
| interferon beta-1a/albumin 22MCG/.5ML PEN INJCTR | Brand Single Source | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 4 | 4 | 3 | 4 | 27 | |||||||||||||
| interferon beta-1a/albumin 22MCG/.5ML SYRINGE | Brand Single Source | 2 | 3 | 8 | 3 | 1 | 4 | 4 | 4 | 6 | 1 | 2 | 1 | 6 | 1 | 4 | 1 | 51 | ||||||||
| interferon beta-1a/albumin 30 MCG KIT | Brand Single Source | 8 | 2 | 4 | 2 | 4 | 2 | 8 | 1 | 5 | 1 | 7 | 2 | 2 | 1 | 7 | 1 | 1 | 1 | 5 | 1 | 65 | ||||
| interferon beta-1a/albumin 44MCG/.5ML PEN INJCTR | Brand Single Source | 30 | 1 | 34 | 3 | 39 | 7 | 30 | 4 | 43 | 2 | 35 | 2 | 38 | 3 | 39 | 1 | 41 | 2 | 36 | 5 | 25 | 2 | 32 | 3 | 457 |
| interferon beta-1a/albumin 44MCG/.5ML SYRINGE | Brand Single Source | 50 | 17 | 68 | 10 | 53 | 9 | 55 | 8 | 52 | 8 | 59 | 10 | 48 | 9 | 54 | 8 | 39 | 8 | 46 | 7 | 54 | 4 | 41 | 6 | 723 |
| interferon beta-1a/albumin 8.8-22(6) PEN INJCTR | Brand Single Source | 3 | 1 | 2 | 1 | 3 | 3 | 1 | 5 | 1 | 4 | 4 | 3 | 1 | 1 | 7 | 1 | 1 | 1 | 43 | ||||||
| interferon beta-1a/albumin 8.8-22(6) SYRINGE | Brand Single Source | 1 | 1 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 12 | |||||||||||||||
| interferon beta-1b 0.3 MG KIT | Brand Originator | 53 | 12 | 44 | 8 | 59 | 12 | 45 | 9 | 56 | 7 | 56 | 10 | 39 | 6 | 48 | 6 | 53 | 6 | 43 | 8 | 34 | 7 | 47 | 5 | 673 |
| interferon gamma-1b,recomb. 100MCG/0.5 VIAL | Brand Single Source | 7 | 3 | 5 | 4 | 3 | 6 | 3 | 3 | 7 | 4 | 4 | 4 | 53 | ||||||||||||
| ledipasvir/sofosbuvir 90MG-400MG TABLET | Brand Originator | 93 | 27 | 96 | 26 | 110 | 33 | 98 | 26 | 94 | 32 | 74 | 22 | 70 | 28 | 110 | 23 | 96 | 27 | 92 | 32 | 106 | 28 | 81 | 20 | 1,444 |
| leuprolide acetate 1 MG/0.2ML KIT | Generic | 5 | 126 | 15 | 110 | 7 | 146 | 2 | 91 | 9 | 141 | 17 | 79 | 24 | 97 | 21 | 89 | 27 | 80 | 14 | 79 | 11 | 61 | 16 | 99 | 1,366 |
| leuprolide acetate 11.25 MG KIT | Brand Single Source | 4 | 5 | 3 | 4 | 2 | 2 | 2 | 5 | 1 | 1 | 2 | 2 | 1 | 5 | 3 | 2 | 3 | 1 | 48 | ||||||
| leuprolide acetate 11.25 MG SYRINGEKIT | Brand Single Source | 47 | 12 | 42 | 11 | 39 | 15 | 37 | 18 | 51 | 9 | 34 | 6 | 34 | 16 | 40 | 15 | 34 | 10 | 35 | 12 | 40 | 11 | 33 | 24 | 625 |
| leuprolide acetate 15 MG KIT | Brand Single Source | 12 | 6 | 1 | 8 | 1 | 5 | 1 | 7 | 6 | 1 | 2 | 3 | 1 | 5 | 1 | 5 | 1 | 5 | 5 | 1 | 77 | ||||
| leuprolide acetate 22.5 MG SYRINGE | Brand Single Source | 2 | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 1 | 3 | 3 | 1 | 1 | 3 | 2 | 28 | |||||||||
| leuprolide acetate 22.5 MG SYRINGEKIT | Brand Single Source | 13 | 10 | 9 | 3 | 15 | 6 | 10 | 4 | 8 | 7 | 17 | 4 | 8 | 2 | 13 | 10 | 6 | 2 | 9 | 3 | 9 | 6 | 8 | 2 | 184 |
| leuprolide acetate 3.75 MG SYRINGEKIT | Brand Single Source | 47 | 28 | 37 | 32 | 41 | 30 | 41 | 27 | 42 | 16 | 53 | 28 | 46 | 15 | 47 | 20 | 47 | 19 | 30 | 20 | 50 | 21 | 32 | 19 | 788 |
| leuprolide acetate 30 MG SYRINGE | Brand Single Source | 1 | 1 | 1 | 2 | 1 | 1 | 7 | ||||||||||||||||||
| leuprolide acetate 30 MG SYRINGEKIT | Brand Single Source | 21 | 2 | 29 | 2 | 27 | 2 | 27 | 4 | 25 | 3 | 28 | 5 | 21 | 4 | 24 | 4 | 21 | 4 | 18 | 2 | 28 | 6 | 18 | 3 | 328 |
| leuprolide acetate 45 MG SYRINGE | Brand Single Source | 2 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 1 | 14 | ||||||||||||||
| leuprolide acetate 45 MG SYRINGEKIT | Brand Single Source | 1 | 1 | 7 | 1 | 5 | 2 | 2 | 2 | 3 | 1 | 3 | 1 | 2 | 1 | 5 | 3 | 3 | 1 | 6 | 1 | 7 | 3 | 61 | ||
| leuprolide acetate 7.5 MG KIT | Brand Single Source | 3 | 4 | 2 | 1 | 3 | 3 | 1 | 2 | 1 | 5 | 3 | 3 | 3 | 3 | 1 | 38 | |||||||||
| leuprolide acetate 7.5 MG SYRINGE | Brand Single Source | 1 | 4 | 2 | 4 | 1 | 1 | 1 | 1 | 15 | ||||||||||||||||
| leuprolide acetate 7.5 MG SYRINGEKIT | Brand Single Source | 7 | 2 | 7 | 2 | 4 | 2 | 3 | 5 | 7 | 2 | 5 | 2 | 7 | 1 | 3 | 1 | 7 | 1 | 3 | 3 | 2 | 2 | 2 | 5 | 85 |
| octreotide acetate 100 MCG/ML AMPUL | Brand Originator | 1 | 1 | 1 | 1 | 3 | 1 | 4 | 2 | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 24 | |||||||||
| octreotide acetate 100 MCG/ML AMPUL | Generic | 1 | 1 | |||||||||||||||||||||||
| octreotide acetate 100 MCG/ML SYRINGE | Brand Single Source | 12 | 2 | 2 | 3 | 3 | 2 | 5 | 1 | 5 | 2 | 3 | 8 | 3 | 6 | 4 | 7 | 2 | 3 | 10 | 5 | 3 | 2 | 3 | 6 | 102 |
| octreotide acetate 100 MCG/ML VIAL | Generic | 2 | 5 | 2 | 7 | 1 | 6 | 2 | 6 | 2 | 5 | 2 | 9 | 4 | 8 | 8 | 2 | 4 | 1 | 4 | 2 | 10 | 3 | 11 | 106 | |
| octreotide acetate 1000MCG/ML VIAL | Brand Originator | 8 | 1 | 6 | 10 | 1 | 6 | 1 | 5 | 1 | 7 | 9 | 4 | 5 | 1 | 7 | 1 | 4 | 6 | 83 | ||||||
| octreotide acetate 1000MCG/ML VIAL | Generic | 2 | 5 | 1 | 3 | 2 | 1 | 1 | 5 | 1 | 1 | 1 | 5 | 28 | ||||||||||||
| octreotide acetate 200 MCG/ML VIAL | Brand Originator | 5 | 6 | 4 | 3 | 4 | 8 | 2 | 6 | 3 | 5 | 5 | 2 | 53 | ||||||||||||
| octreotide acetate 200 MCG/ML VIAL | Generic | 2 | 3 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 21 | ||||||||||||
| octreotide acetate 50 MCG/ML AMPUL | Brand Originator | 1 | 2 | 5 | 6 | 1 | 9 | 1 | 7 | 8 | 2 | 1 | 1 | 1 | 45 | |||||||||||
| octreotide acetate 50 MCG/ML AMPUL | Generic | 1 | 1 | 2 | ||||||||||||||||||||||
| octreotide acetate 50 MCG/ML SYRINGE | Brand Single Source | 5 | 6 | 2 | 2 | 7 | 1 | 4 | 2 | 5 | 1 | 6 | 2 | 3 | 1 | 3 | 1 | 6 | 2 | 4 | 4 | 6 | 4 | 77 | ||
| octreotide acetate 50 MCG/ML VIAL | Generic | 2 | 2 | 3 | 6 | 7 | 6 | 2 | 3 | 5 | 5 | 5 | 2 | 48 | ||||||||||||
| octreotide acetate 500 MCG/ML AMPUL | Brand Originator | 1 | 1 | |||||||||||||||||||||||
| octreotide acetate 500 MCG/ML SYRINGE | Brand Single Source | 1 | 1 | 1 | 1 | 4 | ||||||||||||||||||||
| octreotide acetate 500 MCG/ML VIAL | Generic | 1 | 1 | 1 | 3 | |||||||||||||||||||||
| ombita/paritap/riton/dasabuvir 12.5-75-50 TAB DS PK | Brand Single Source | 1 | 1 | 1 | 1 | 4 | ||||||||||||||||||||
| ombita/paritap/riton/dasabuvir 8.33-50 MG TAB BP 24H | Brand Single Source | 2 | 1 | 1 | 1 | 1 | 1 | 7 | ||||||||||||||||||
| pazopanib HCl 200 MG TABLET | Brand Single Source | 46 | 81 | 38 | 78 | 48 | 86 | 48 | 75 | 63 | 90 | 108 | 27 | 123 | 19 | 127 | 22 | 121 | 20 | 102 | 24 | 113 | 27 | 100 | 24 | 1,610 |
| pegfilgrastim 6 MG/0.6ML SYR W/ INJ | Brand Single Source | 3 | 9 | 2 | 11 | 3 | 8 | 3 | 11 | 2 | 10 | 3 | 8 | 4 | 1 | 8 | 1 | 7 | 7 | 2 | 12 | 5 | 8 | 128 | ||
| pegfilgrastim 6 MG/0.6ML SYRINGE | Brand Single Source | 28 | 29 | 18 | 24 | 25 | 24 | 19 | 22 | 22 | 29 | 27 | 26 | 18 | 23 | 23 | 36 | 29 | 24 | 38 | 28 | 29 | 33 | 30 | 31 | 635 |
| peginterferon alfa-2a 135MCG/0.5 PEN INJCTR | Brand Single Source | 1 | 1 | 1 | 1 | 4 | ||||||||||||||||||||
| peginterferon alfa-2a 180MCG/0.5 PEN INJCTR | Brand Single Source | 1 | 1 | |||||||||||||||||||||||
| peginterferon alfa-2a 180MCG/0.5 SYRINGE | Brand Single Source | 1 | 2 | 1 | 3 | 3 | 2 | 1 | 2 | 1 | 2 | 2 | 2 | 1 | 2 | 1 | 1 | 27 | ||||||||
| peginterferon alfa-2a 180MCG/ML VIAL | Brand Single Source | 1 | 1 | 4 | 2 | 7 | 1 | 3 | 6 | 3 | 2 | 5 | 3 | 5 | 2 | 4 | 1 | 3 | 1 | 3 | 1 | 4 | 1 | 63 | ||
| peginterferon alfa-2b 200 MCG KIT | Brand Single Source | 1 | 1 | 1 | 1 | 1 | 5 | |||||||||||||||||||
| peginterferon alfa-2b 300 MCG KIT | Brand Single Source | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 9 | ||||||||||||||||
| ribavirin 200 MG CAPSULE | Generic | 6 | 3 | 4 | 6 | 5 | 8 | 2 | 4 | 3 | 3 | 1 | 2 | 1 | 2 | 1 | 2 | 2 | 1 | 4 | 4 | 5 | 69 | |||
| ribavirin 200 MG TABLET | Generic | 8 | 7 | 9 | 3 | 9 | 3 | 5 | 8 | 1 | 5 | 4 | 4 | 6 | 12 | 5 | 4 | 3 | 1 | 3 | 2 | 5 | 3 | 1 | 111 | |
| ribavirin 400-400 MG TAB DS PK | Generic | 1 | 1 | |||||||||||||||||||||||
| ribavirin 600 MG TABLET | Brand Single Source | 1 | 1 | 2 | ||||||||||||||||||||||
| ribavirin 600-400 MG TAB DS PK | Brand Single Source | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 11 | ||||||||||||||
| ribavirin 600-600 MG TAB DS PK | Brand Single Source | 2 | 1 | 3 | ||||||||||||||||||||||
| ribavirin 600-600 MG TAB DS PK | Generic | 1 | 1 | |||||||||||||||||||||||
| sargramostim 250 MCG VIAL | Brand Single Source | 2 | 3 | 3 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 4 | 2 | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 37 | ||||
| sofosbuvir 400 MG TABLET | Brand Single Source | 10 | 1 | 4 | 1 | 3 | 3 | 2 | 1 | 1 | 1 | 2 | 1 | 4 | 1 | 1 | 2 | 1 | 2 | 2 | 1 | 44 | ||||
| sofosbuvir/velpatasvir 400-100 MG TABLET | Brand Originator | 21 | 45 | 15 | 51 | 24 | 61 | 21 | 47 | 26 | 54 | 48 | 17 | 44 | 17 | 33 | 15 | 25 | 12 | 26 | 11 | 25 | 15 | 25 | 17 | 695 |
| sorafenib tosylate 200 MG TABLET | Brand Single Source | 20 | 35 | 21 | 35 | 33 | 41 | 28 | 31 | 30 | 37 | 45 | 12 | 55 | 11 | 54 | 10 | 50 | 9 | 60 | 9 | 50 | 7 | 55 | 7 | 745 |
| sunitinib malate 12.5 MG CAPSULE | Brand Single Source | 10 | 7 | 2 | 18 | 1 | 9 | 8 | 2 | 11 | 1 | 18 | 1 | 15 | 2 | 11 | 3 | 15 | 7 | 1 | 13 | 155 | ||||
| sunitinib malate 25 MG CAPSULE | Brand Single Source | 20 | 1 | 17 | 1 | 16 | 12 | 2 | 16 | 2 | 19 | 4 | 18 | 2 | 15 | 2 | 17 | 3 | 18 | 3 | 26 | 3 | 22 | 3 | 242 | |
| sunitinib malate 37.5 MG CAPSULE | Brand Single Source | 16 | 4 | 20 | 4 | 19 | 6 | 19 | 6 | 22 | 8 | 26 | 5 | 23 | 2 | 20 | 4 | 27 | 3 | 19 | 5 | 22 | 5 | 17 | 6 | 308 |
| sunitinib malate 50 MG CAPSULE | Brand Single Source | 29 | 6 | 32 | 7 | 24 | 13 | 23 | 4 | 24 | 3 | 29 | 3 | 22 | 3 | 28 | 8 | 21 | 5 | 26 | 5 | 18 | 9 | 13 | 3 | 358 |
| teriflunomide 14 MG TABLET | Brand Single Source | 206 | 13 | 178 | 16 | 238 | 21 | 181 | 15 | 208 | 19 | 216 | 20 | 197 | 15 | 196 | 16 | 187 | 14 | 193 | 17 | 172 | 17 | 196 | 11 | 2,562 |
| teriflunomide 7 MG TABLET | Brand Single Source | 10 | 3 | 15 | 4 | 13 | 3 | 16 | 3 | 20 | 3 | 23 | 3 | 14 | 4 | 15 | 4 | 18 | 2 | 22 | 2 | 23 | 1 | 20 | 1 | 242 |
| teriparatide 20MCG/DOSE PEN INJCTR | Brand Single Source | 895 | 183 | 687 | 176 | 905 | 208 | 719 | 181 | 869 | 204 | 793 | 201 | 825 | 181 | 856 | 197 | 723 | 194 | 819 | 197 | 786 | 195 | 763 | 190 | 11,947 |
| tocilizumab 162 MG/0.9 SYRINGE | Brand Single Source | 155 | 18 | 124 | 15 | 151 | 20 | 135 | 18 | 153 | 17 | 183 | 25 | 162 | 19 | 187 | 19 | 155 | 19 | 179 | 17 | 170 | 15 | 166 | 18 | 2,140 |
| tofacitinib citrate 5 MG TABLET | Brand Single Source | 391 | 58 | 375 | 50 | 363 | 51 | 367 | 44 | 376 | 49 | 356 | 48 | 378 | 55 | 351 | 42 | 346 | 41 | 392 | 48 | 321 | 43 | 331 | 36 | 4,912 |
| ustekinumab 45MG/0.5ML SYRINGE | Brand Single Source | 206 | 18 | 179 | 36 | 205 | 38 | 182 | 30 | 204 | 14 | 217 | 26 | 186 | 25 | 210 | 24 | 199 | 19 | 205 | 24 | 209 | 26 | 194 | 15 | 2,691 |
| ustekinumab 90 MG/ML SYRINGE | Brand Single Source | 180 | 15 | 154 | 14 | 177 | 32 | 167 | 25 | 189 | 30 | 213 | 26 | 197 | 26 | 228 | 21 | 208 | 23 | 240 | 26 | 224 | 20 | 213 | 34 | 2,682 |
| Grand Total | 12,716 | 3,064 | 11,092 | 3,008 | 12,637 | 3,346 | 11,427 | 2,956 | 12,761 | 3,229 | 12,471 | 2,767 | 12,349 | 2,608 | 12,882 | 2,762 | 11,474 | 2,479 | 12,437 | 2,607 | 12,028 | 2,491 | 11,609 | 2,456 | 179,656 |
Specialty Drugs 2018
| FOR OFFICIAL USE ONLY | ||||||||||||||||||||||||||
| Title: Retail & Mail Order Specialty Drug RX Volume | ||||||||||||||||||||||||||
| Date Range: 1/1/2018 - 12/31/2018 | ||||||||||||||||||||||||||
| Jan-18 | Feb-18 | Mar-18 | Apr-18 | May-18 | Jun-18 | Jul-18 | Aug-18 | Sep-18 | Oct-18 | Nov-18 | Dec-18 | Grand Total | ||||||||||||||
| # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | # RX | ||
| Drug/Strength/Form | Brand/Generic Indicator | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | Mail Order | Retail | |
| abatacept 125 MG/ML AUTO INJCT | Brand Single Source | 140 | 12 | 141 | 12 | 147 | 12 | 129 | 10 | 152 | 15 | 135 | 21 | 165 | 19 | 181 | 23 | 147 | 13 | 207 | 24 | 183 | 23 | 180 | 27 | 2,118 |
| abatacept 125 MG/ML SYRINGE | Brand Single Source | 243 | 45 | 222 | 45 | 225 | 48 | 221 | 46 | 250 | 50 | 204 | 50 | 238 | 44 | 242 | 45 | 191 | 36 | 224 | 38 | 224 | 34 | 214 | 31 | 3,210 |
| abatacept 50MG/0.4ML SYRINGE | Brand Single Source | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 | ||||||||||||||||
| abatacept 87.5MG/0.7 SYRINGE | Brand Single Source | 2 | 3 | 1 | 3 | 3 | 1 | 1 | 2 | 2 | 1 | 2 | 1 | 22 | ||||||||||||
| adalimumab 10MG/0.1ML SYRINGEKIT | Brand Single Source | 1 | 1 | 1 | 1 | 1 | 1 | 6 | ||||||||||||||||||
| adalimumab 10MG/0.2ML SYRINGEKIT | Brand Single Source | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 9 | ||||||||||||||||
| adalimumab 20MG/0.2ML SYRINGEKIT | Brand Single Source | 6 | 10 | 17 | 23 | 23 | 24 | 2 | 24 | 129 | ||||||||||||||||
| adalimumab 20MG/0.4ML SYRINGEKIT | Brand Single Source | 23 | 29 | 21 | 1 | 30 | 22 | 24 | 18 | 19 | 8 | 10 | 1 | 7 | 1 | 9 | 223 | |||||||||
| adalimumab 40MG/0.4ML PEN IJ KIT | Brand Single Source | 5 | 20 | 35 | 100 | 6 | 213 | 34 | 446 | 78 | 575 | 90 | 674 | 129 | 2,405 | |||||||||||
| adalimumab 40MG/0.4ML SYRINGEKIT | Brand Single Source | 11 | 19 | 24 | 8 | 58 | 17 | 79 | 17 | 113 | 20 | 114 | 27 | 507 | ||||||||||||
| adalimumab 40MG/0.8ML PEN IJ KIT | Brand Single Source | 3,813 | 445 | 3,304 | 408 | 3,528 | 451 | 3,560 | 414 | 3,622 | 450 | 3,470 | 393 | 3,574 | 422 | 3,605 | 425 | 3,154 | 361 | 3,310 | 370 | 2,864 | 298 | 2,684 | 262 | 45,187 |
| adalimumab 40MG/0.8ML SYRINGEKIT | Brand Single Source | 638 | 108 | 571 | 86 | 625 | 104 | 622 | 104 | 580 | 109 | 581 | 89 | 608 | 93 | 579 | 92 | 547 | 94 | 517 | 100 | 532 | 83 | 444 | 79 | 7,985 |
| adalimumab 80 MG-40MG PEN IJ KIT | Brand Single Source | 2 | 2 | 8 | 8 | 21 | 10 | 16 | 17 | 20 | 23 | 127 | ||||||||||||||
| adalimumab 80 MG-40MG SYRINGEKIT | Brand Single Source | 1 | 2 | 2 | 2 | 1 | 2 | 10 | ||||||||||||||||||
| adalimumab 80MG/0.8ML PEN IJ KIT | Brand Single Source | 4 | 3 | 15 | 6 | 23 | 12 | 11 | 18 | 23 | 16 | 131 | ||||||||||||||
| adalimumab 80MG/0.8ML SYRINGEKIT | Brand Single Source | 2 | 2 | 1 | 1 | 1 | 2 | 9 | ||||||||||||||||||
| anakinra 100MG/0.67 SYRINGE | Brand Single Source | 26 | 2 | 20 | 4 | 17 | 3 | 20 | 2 | 17 | 3 | 20 | 7 | 16 | 3 | 16 | 3 | 16 | 3 | 18 | 11 | 18 | 3 | 24 | 4 | 276 |
| antihemophil.FVIII,full length 1000 (+/-) VIAL | Brand Originator | 20 | 15 | 14 | 20 | 13 | 19 | 17 | 29 | 19 | 21 | 19 | 18 | 224 | ||||||||||||
| antihemophil.FVIII,full length 1500 (+/-) VIAL | Brand Single Source | 5 | 6 | 6 | 5 | 8 | 8 | 6 | 13 | 13 | 10 | 12 | 8 | 100 | ||||||||||||
| antihemophil.FVIII,full length 2000 (+/-) VIAL | Brand Originator | 16 | 16 | 20 | 11 | 17 | 17 | 13 | 11 | 9 | 13 | 10 | 13 | 166 | ||||||||||||
| antihemophil.FVIII,full length 250 (+/-) VIAL | Brand Originator | 11 | 8 | 8 | 12 | 12 | 7 | 10 | 8 | 10 | 8 | 9 | 9 | 112 | ||||||||||||
| antihemophil.FVIII,full length 3000 (+/-) VIAL | Brand Originator | 14 | 12 | 10 | 13 | 15 | 12 | 14 | 13 | 10 | 13 | 7 | 7 | 140 | ||||||||||||
| antihemophil.FVIII,full length 4000 (+/-) VIAL | Brand Single Source | 1 | 3 | 2 | 1 | 2 | 1 | 1 | 1 | 12 | ||||||||||||||||
| antihemophil.FVIII,full length 500 (+/-) VIAL | Brand Originator | 24 | 21 | 22 | 26 | 20 | 14 | 12 | 15 | 15 | 17 | 12 | 13 | 211 | ||||||||||||
| antihemophilic factor, hum rec 1000 (+/-) VIAL | Brand Single Source | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 10 | ||||||||||||||||
| antihemophilic factor, hum rec 1500 (+/-) VIAL | Brand Single Source | 2 | 1 | 2 | 2 | 1 | 2 | 2 | 1 | 1 | 14 | |||||||||||||||
| antihemophilic factor, hum rec 2000 (+/-) VIAL | Brand Single Source | 4 | 1 | 3 | 2 | 4 | 4 | 4 | 3 | 3 | 1 | 3 | 1 | 33 | ||||||||||||
| antihemophilic factor, hum rec 250 (+/-) VIAL | Brand Single Source | 1 | 1 | 1 | 1 | 4 | ||||||||||||||||||||
| antihemophilic factor, hum rec 500 (+/-) VIAL | Brand Single Source | 1 | 1 | 1 | 1 | 3 | 1 | 2 | 2 | 1 | 1 | 14 | ||||||||||||||
| antihemophilic factor, human 1000 (+/-) VIAL | Brand Originator | 1 | 1 | |||||||||||||||||||||||
| antihemophilic factor, human 1000 (+/-) VIAL | Brand Single Source | 1 | 1 | 2 | ||||||||||||||||||||||
| antihemophilic factor, human 250 (+/-) VIAL | Brand Single Source | 1 | 1 | 2 | 1 | 1 | 1 | 7 | ||||||||||||||||||
| antihemophilic factor, human 500 (+/-) VIAL | Brand Single Source | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 9 | |||||||||||||||||
| antihemophilic factor/VWF 1000 (400) VIAL | Brand Single Source | 1 | 2 | 3 | 2 | 2 | 2 | 2 | 4 | 1 | 2 | 3 | 3 | 27 | ||||||||||||
| antihemophilic factor/VWF 1000-2400 VIAL | Brand Single Source | 4 | 3 | 4 | 11 | 5 | 3 | 5 | 5 | 4 | 4 | 5 | 5 | 58 | ||||||||||||
| antihemophilic factor/VWF 1500 (600) VIAL | Brand Single Source | 1 | 1 | 1 | 1 | 1 | 3 | 2 | 10 | |||||||||||||||||
| antihemophilic factor/VWF 1K-1K UNIT VIAL | Brand Single Source | 7 | 3 | 4 | 1 | 3 | 3 | 7 | 3 | 3 | 6 | 6 | 4 | 50 | ||||||||||||
| antihemophilic factor/VWF 2000 (800) VIAL | Brand Single Source | 6 | 4 | 3 | 4 | 4 | 2 | 2 | 2 | 3 | 4 | 2 | 5 | 41 | ||||||||||||
| antihemophilic factor/VWF 250 (100) VIAL | Brand Single Source | 1 | 1 | 2 | 3 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 16 | |||||||||||||
| antihemophilic factor/VWF 250-600 VIAL | Brand Single Source | 2 | 2 | 6 | 1 | 1 | 3 | 1 | 16 | |||||||||||||||||
| antihemophilic factor/VWF 500 (200) VIAL | Brand Single Source | 3 | 3 | 1 | 2 | 3 | 3 | 1 | 1 | 3 | 1 | 2 | 23 | |||||||||||||
| antihemophilic factor/VWF 500-1200 VIAL | Brand Single Source | 1 | 3 | 2 | 9 | 1 | 2 | 2 | 3 | 1 | 3 | 1 | 1 | 29 | ||||||||||||
| antihemophilic factor/VWF 500-500 VIAL | Brand Single Source | 1 | 1 | 1 | 3 | |||||||||||||||||||||
| apremilast 10-20-30MG TAB DS PK | Brand Single Source | 10 | 13 | 9 | 10 | 27 | 14 | 28 | 16 | 23 | 17 | 13 | 11 | 18 | 12 | 8 | 11 | 10 | 16 | 22 | 18 | 15 | 11 | 15 | 16 | 363 |
| apremilast 30 MG TABLET | Brand Single Source | 779 | 103 | 707 | 114 | 788 | 101 | 783 | 106 | 826 | 119 | 809 | 121 | 781 | 106 | 856 | 114 | 772 | 98 | 863 | 137 | 797 | 133 | 811 | 124 | 10,948 |
| axitinib 1 MG TABLET | Brand Single Source | 8 | 7 | 2 | 6 | 9 | 5 | 1 | 7 | 1 | 5 | 2 | 3 | 1 | 6 | 1 | 5 | 6 | 1 | 76 | ||||||
| axitinib 5 MG TABLET | Brand Single Source | 13 | 2 | 13 | 2 | 19 | 5 | 10 | 3 | 17 | 4 | 11 | 5 | 15 | 2 | 11 | 5 | 15 | 1 | 10 | 1 | 11 | 1 | 13 | 1 | 190 |
| bexarotene 1 % GEL (GRAM) | Brand Single Source | 2 | 5 | 1 | 2 | 1 | 6 | 3 | 1 | 3 | 4 | 3 | 2 | 4 | 1 | 1 | 1 | 2 | 42 | |||||||
| bexarotene 75 MG CAPSULE | Brand Originator | 12 | 11 | 10 | 9 | 12 | 8 | 12 | 9 | 12 | 13 | 12 | 7 | 127 | ||||||||||||
| bexarotene 75 MG CAPSULE | Generic | 4 | 6 | 13 | 7 | 9 | 8 | 9 | 13 | 10 | 6 | 8 | 6 | 4 | 103 | |||||||||||
| bosentan 125 MG TABLET | Brand Originator | 105 | 98 | 94 | 101 | 97 | 89 | 96 | 88 | 77 | 88 | 87 | 79 | 1,099 | ||||||||||||
| bosentan 32 MG TAB SUSP | Brand Single Source | 1 | 1 | 1 | 1 | 3 | 1 | 2 | 1 | 1 | 1 | 1 | 14 | |||||||||||||
| bosentan 62.5 MG TABLET | Brand Originator | 18 | 15 | 18 | 18 | 17 | 16 | 17 | 19 | 13 | 16 | 13 | 16 | 196 | ||||||||||||
| certolizumab pegol 400 MG KIT | Brand Single Source | 4 | 8 | 6 | 11 | 6 | 7 | 1 | 4 | 1 | 10 | 7 | 8 | 1 | 7 | 10 | 91 | |||||||||
| certolizumab pegol 400MG/2ML SYRINGEKIT | Brand Single Source | 249 | 27 | 206 | 28 | 244 | 26 | 230 | 32 | 234 | 27 | 213 | 30 | 249 | 36 | 229 | 29 | 216 | 29 | 247 | 23 | 230 | 27 | 221 | 25 | 3,107 |
| coagulation factor VIIa,recomb 1 MG VIAL | Brand Single Source | 3 | 1 | 2 | 1 | 7 | ||||||||||||||||||||
| coagulation factor VIIa,recomb 2 MG VIAL | Brand Single Source | 2 | 3 | 1 | 3 | 1 | 1 | 2 | 3 | 16 | ||||||||||||||||
| coagulation factor VIIa,recomb 5 MG VIAL | Brand Single Source | 2 | 1 | 3 | 6 | |||||||||||||||||||||
| coagulation factor VIIa,recomb 8 MG VIAL | Brand Single Source | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8 | ||||||||||||||||
| darbepoetin alfa in polysorbat 100 MCG/ML VIAL | Brand Single Source | 3 | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 3 | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 31 | |||
| darbepoetin alfa in polysorbat 100MCG/0.5 SYRINGE | Brand Single Source | 2 | 3 | 2 | 2 | 3 | 1 | 8 | 1 | 4 | 5 | 6 | 6 | 5 | 3 | 1 | 4 | 3 | 7 | 3 | 2 | 1 | 7 | 9 | 88 | |
| darbepoetin alfa in polysorbat 150MCG/0.3 SYRINGE | Brand Single Source | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 3 | 6 | 2 | 2 | 4 | 3 | 1 | 36 | |||||
| darbepoetin alfa in polysorbat 200 MCG/ML VIAL | Brand Single Source | 2 | 2 | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 25 | |||||||
| darbepoetin alfa in polysorbat 200MCG/0.4 SYRINGE | Brand Single Source | 7 | 6 | 7 | 2 | 7 | 1 | 7 | 2 | 8 | 5 | 9 | 4 | 9 | 2 | 5 | 5 | 7 | 2 | 11 | 3 | 4 | 4 | 7 | 3 | 127 |
| darbepoetin alfa in polysorbat 25 MCG/ML VIAL | Brand Single Source | 1 | 1 | 1 | 3 | 2 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 4 | 1 | 25 | ||||||||||
| darbepoetin alfa in polysorbat 25MCG/0.42 SYRINGE | Brand Single Source | 2 | 2 | 4 | 4 | 1 | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 3 | 2 | 3 | 3 | 5 | 2 | 2 | 2 | 3 | 51 | |||
| darbepoetin alfa in polysorbat 300MCG/0.6 SYRINGE | Brand Single Source | 1 | 7 | 1 | 6 | 5 | 2 | 5 | 4 | 2 | 1 | 4 | 1 | 4 | 3 | 3 | 1 | 2 | 2 | 4 | 4 | 5 | 1 | 1 | 69 | |
| darbepoetin alfa in polysorbat 40 MCG/0.4 SYRINGE | Brand Single Source | 6 | 3 | 5 | 5 | 5 | 8 | 4 | 6 | 5 | 6 | 7 | 4 | 6 | 12 | 8 | 9 | 6 | 9 | 2 | 9 | 3 | 4 | 4 | 2 | 138 |
| darbepoetin alfa in polysorbat 40 MCG/ML VIAL | Brand Single Source | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 3 | 2 | 2 | 2 | 2 | 3 | 1 | 1 | 2 | 28 | |||||||
| darbepoetin alfa in polysorbat 500 MCG/ML SYRINGE | Brand Single Source | 4 | 4 | 5 | 1 | 3 | 3 | 2 | 4 | 3 | 3 | 4 | 4 | 4 | 3 | 3 | 4 | 1 | 2 | 3 | 3 | 1 | 2 | 2 | 68 | |
| darbepoetin alfa in polysorbat 60 MCG/0.3 SYRINGE | Brand Single Source | 9 | 4 | 10 | 2 | 9 | 4 | 3 | 7 | 10 | 6 | 8 | 2 | 8 | 4 | 9 | 4 | 11 | 5 | 4 | 6 | 4 | 9 | 10 | 3 | 151 |
| darbepoetin alfa in polysorbat 60 MCG/ML VIAL | Brand Single Source | 1 | 5 | 2 | 1 | 3 | 1 | 1 | 1 | 15 | ||||||||||||||||
| dasatinib 100 MG TABLET | Brand Single Source | 95 | 19 | 86 | 12 | 101 | 13 | 91 | 13 | 84 | 16 | 88 | 16 | 85 | 14 | 81 | 22 | 78 | 25 | 79 | 19 | 83 | 13 | 75 | 17 | 1,225 |
| dasatinib 140 MG TABLET | Brand Single Source | 5 | 4 | 4 | 3 | 2 | 3 | 1 | 1 | 1 | 4 | 2 | 5 | 2 | 3 | 5 | 2 | 3 | 2 | 3 | 55 | |||||
| dasatinib 20 MG TABLET | Brand Single Source | 17 | 2 | 14 | 2 | 16 | 22 | 1 | 17 | 1 | 18 | 2 | 21 | 1 | 18 | 2 | 23 | 23 | 1 | 22 | 1 | 18 | 1 | 243 | ||
| dasatinib 50 MG TABLET | Brand Single Source | 34 | 6 | 31 | 4 | 32 | 4 | 33 | 5 | 41 | 3 | 31 | 3 | 36 | 2 | 38 | 4 | 23 | 3 | 40 | 2 | 40 | 3 | 27 | 2 | 447 |
| dasatinib 70 MG TABLET | Brand Single Source | 15 | 7 | 10 | 1 | 22 | 5 | 15 | 5 | 17 | 5 | 15 | 6 | 20 | 5 | 16 | 2 | 18 | 2 | 20 | 1 | 14 | 3 | 17 | 3 | 244 |
| dasatinib 80 MG TABLET | Brand Single Source | 12 | 5 | 11 | 5 | 14 | 3 | 8 | 2 | 12 | 4 | 12 | 1 | 14 | 1 | 14 | 2 | 9 | 2 | 13 | 3 | 12 | 1 | 11 | 171 | |
| deferasirox 125 MG TAB DISPER | Brand Originator | 4 | 1 | 3 | 4 | 1 | 2 | 4 | 1 | 5 | 1 | 1 | 3 | 2 | 1 | 1 | 34 | |||||||||
| deferasirox 250 MG TAB DISPER | Brand Originator | 4 | 1 | 1 | 1 | 2 | 2 | 4 | 1 | 2 | 1 | 3 | 2 | 6 | 3 | 1 | 1 | 4 | 2 | 6 | 2 | 4 | 3 | 56 | ||
| deferasirox 500 MG TAB DISPER | Brand Originator | 10 | 2 | 5 | 3 | 10 | 1 | 12 | 1 | 9 | 1 | 6 | 2 | 5 | 1 | 12 | 1 | 10 | 2 | 7 | 1 | 7 | 3 | 6 | 3 | 120 |
| desmopressin (nonrefrigerated) 10/SPRAY SPRAY/PUMP | Brand Originator | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 2 | 1 | 15 | |||||||||||||
| desmopressin (nonrefrigerated) 10/SPRAY SPRAY/PUMP | Generic | 63 | 35 | 37 | 36 | 54 | 47 | 40 | 39 | 44 | 53 | 47 | 48 | 35 | 46 | 51 | 49 | 47 | 45 | 47 | 61 | 50 | 50 | 42 | 49 | 1,115 |
| desmopressin acetate 0.1 MG/ML SOLUTION | Brand Single Source | 3 | 1 | 1 | 1 | 2 | 3 | 1 | 3 | 3 | 2 | 2 | 1 | 2 | 2 | 1 | 2 | 1 | 31 | |||||||
| desmopressin acetate 10/SPRAY SPRAY/PUMP | Generic | 23 | 13 | 25 | 18 | 22 | 14 | 19 | 19 | 19 | 16 | 20 | 14 | 222 | ||||||||||||
| desmopressin acetate 150/SPRAY SPRAY/PUMP | Brand Single Source | 5 | 9 | 5 | 9 | 10 | 19 | 10 | 13 | 5 | 17 | 7 | 10 | 15 | 18 | 13 | 15 | 10 | 14 | 20 | 23 | 247 | ||||
| desmopressin acetate 4 MCG/ML AMPUL | Generic | 2 | 3 | 1 | 1 | 7 | ||||||||||||||||||||
| desmopressin acetate 4 MCG/ML VIAL | Brand Originator | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 23 | |||||
| desmopressin acetate 4 MCG/ML VIAL | Generic | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 3 | 2 | 2 | 2 | 19 | |||||||||||||
| dimethyl fumarate 120 MG CAPSULE DR | Brand Single Source | 6 | 2 | 5 | 2 | 7 | 1 | 4 | 1 | 8 | 6 | 8 | 1 | 4 | 1 | 7 | 10 | 5 | 4 | 82 | ||||||
| dimethyl fumarate 120-240 MG CAPSULE DR | Brand Single Source | 13 | 21 | 19 | 22 | 26 | 1 | 16 | 2 | 17 | 2 | 12 | 1 | 19 | 18 | 1 | 21 | 1 | 12 | 1 | 225 | |||||
| dimethyl fumarate 240 MG CAPSULE DR | Brand Single Source | 318 | 86 | 266 | 87 | 288 | 85 | 276 | 83 | 291 | 91 | 284 | 67 | 298 | 71 | 282 | 76 | 277 | 68 | 291 | 79 | 294 | 76 | 263 | 58 | 4,355 |
| epoetin alfa 10000/ML VIAL | Brand Originator | 37 | 33 | 24 | 40 | 50 | 34 | 28 | 32 | 33 | 51 | 30 | 42 | 29 | 40 | 53 | 41 | 28 | 41 | 38 | 61 | 32 | 51 | 34 | 47 | 929 |
| epoetin alfa 2000/ML VIAL | Brand Originator | 2 | 3 | 1 | 2 | 2 | 2 | 1 | 5 | 3 | 5 | 2 | 9 | 1 | 7 | 6 | 6 | 3 | 2 | 2 | 3 | 2 | 5 | 1 | 2 | 77 |
| epoetin alfa 20000/2ML VIAL | Brand Originator | 2 | 8 | 4 | 4 | 4 | 3 | 2 | 4 | 4 | 2 | 6 | 4 | 3 | 4 | 1 | 4 | 2 | 5 | 5 | 2 | 2 | 2 | 77 | ||
| epoetin alfa 20000/ML VIAL | Brand Originator | 35 | 45 | 35 | 37 | 31 | 57 | 6 | 44 | 16 | 45 | 48 | 41 | 38 | 64 | 31 | 60 | 34 | 41 | 28 | 52 | 32 | 42 | 26 | 30 | 918 |
| epoetin alfa 3000/ML VIAL | Brand Originator | 2 | 1 | 3 | 2 | 1 | 2 | 2 | 1 | 3 | 2 | 4 | 1 | 1 | 3 | 1 | 5 | 1 | 4 | 39 | ||||||
| epoetin alfa 4000/ML VIAL | Brand Originator | 7 | 5 | 7 | 9 | 6 | 4 | 5 | 5 | 7 | 9 | 9 | 4 | 11 | 9 | 5 | 6 | 12 | 3 | 5 | 5 | 4 | 3 | 11 | 5 | 156 |
| epoetin alfa 40000/ML VIAL | Brand Single Source | 48 | 35 | 31 | 37 | 34 | 40 | 41 | 30 | 42 | 27 | 37 | 32 | 37 | 28 | 37 | 24 | 40 | 29 | 43 | 23 | 29 | 27 | 35 | 22 | 808 |
| etanercept 25 MG VIAL | Brand Single Source | 62 | 11 | 65 | 12 | 73 | 11 | 69 | 12 | 55 | 9 | 71 | 12 | 55 | 14 | 65 | 15 | 50 | 12 | 68 | 12 | 59 | 12 | 56 | 8 | 888 |
| etanercept 25MG/0.5ML SYRINGE | Brand Single Source | 72 | 18 | 47 | 15 | 55 | 13 | 42 | 7 | 70 | 9 | 57 | 10 | 50 | 11 | 52 | 8 | 47 | 10 | 44 | 14 | 55 | 11 | 47 | 7 | 771 |
| etanercept 50MG/ML(1) CARTRIDGE | Brand Single Source | 5 | 1 | 9 | 3 | 24 | 1 | 33 | 2 | 36 | 5 | 52 | 6 | 49 | 8 | 65 | 5 | 87 | 12 | 87 | 7 | 98 | 5 | 108 | 7 | 715 |
| etanercept 50MG/ML(1) PEN INJCTR | Brand Single Source | 1,225 | 165 | 991 | 129 | 1,074 | 132 | 1,060 | 135 | 1,079 | 119 | 1,010 | 117 | 1,086 | 127 | 1,055 | 135 | 942 | 110 | 1,048 | 121 | 1,009 | 115 | 920 | 112 | 14,016 |
| etanercept 50MG/ML(1) SYRINGE | Brand Single Source | 414 | 42 | 326 | 38 | 398 | 42 | 390 | 37 | 395 | 45 | 369 | 31 | 371 | 33 | 402 | 42 | 344 | 31 | 390 | 40 | 318 | 29 | 346 | 32 | 4,905 |
| everolimus 10 MG TABLET | Brand Single Source | 63 | 24 | 47 | 20 | 55 | 16 | 50 | 18 | 58 | 15 | 59 | 16 | 54 | 12 | 48 | 12 | 61 | 16 | 62 | 18 | 54 | 14 | 52 | 22 | 866 |
| everolimus 2 MG TAB SUSP | Brand Single Source | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 4 | 19 | |||||||||||
| everolimus 2.5 MG TABLET | Brand Single Source | 5 | 4 | 3 | 4 | 2 | 3 | 4 | 3 | 3 | 1 | 6 | 2 | 5 | 2 | 2 | 3 | 5 | 1 | 5 | 3 | 1 | 1 | 6 | 2 | 76 |
| everolimus 3 MG TAB SUSP | Brand Single Source | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 3 | 3 | 14 | |||||||||||||||
| everolimus 5 MG TAB SUSP | Brand Single Source | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 2 | 2 | 2 | 1 | 3 | 1 | 2 | 2 | 1 | 1 | 2 | 29 | |||||
| everolimus 5 MG TABLET | Brand Single Source | 39 | 9 | 29 | 7 | 44 | 11 | 39 | 6 | 43 | 9 | 41 | 9 | 36 | 8 | 47 | 10 | 45 | 14 | 49 | 12 | 47 | 11 | 51 | 12 | 628 |
| everolimus 7.5 MG TABLET | Brand Single Source | 12 | 6 | 9 | 3 | 15 | 5 | 14 | 4 | 13 | 5 | 11 | 5 | 12 | 4 | 14 | 4 | 6 | 5 | 13 | 6 | 14 | 6 | 13 | 6 | 205 |
| factor IX 1000 (+/-) VIAL | Brand Originator | 2 | 1 | 1 | 1 | 1 | 1 | 7 | ||||||||||||||||||
| factor IX 1500 (+/-) VIAL | Brand Single Source | 1 | 1 | 1 | 1 | 1 | 5 | |||||||||||||||||||
| factor IX human recombinant 1000 UNIT VIAL | Brand Originator | 1 | 1 | 2 | 4 | 2 | 1 | 2 | 3 | 1 | 3 | 20 | ||||||||||||||
| factor IX human recombinant 2000 UNIT VIAL | Brand Originator | 3 | 2 | 2 | 5 | 4 | 4 | 1 | 1 | 2 | 1 | 3 | 2 | 30 | ||||||||||||
| factor IX human recombinant 250 UNIT VIAL | Brand Originator | 1 | 1 | 2 | 4 | |||||||||||||||||||||
| factor IX human recombinant 3000 UNIT VIAL | Brand Originator | 1 | 3 | 3 | 7 | 1 | 2 | 2 | 1 | 3 | 4 | 3 | 30 | |||||||||||||
| factor IX human recombinant 500 UNIT VIAL | Brand Originator | 1 | 1 | 2 | 2 | 1 | 1 | 2 | 3 | 4 | 3 | 20 | ||||||||||||||
| factor XIII 1000-1600 VIAL | Brand Single Source | 2 | 1 | 2 | 1 | 2 | 1 | 2 | 2 | 3 | 2 | 3 | 21 | |||||||||||||
| filgrastim 300 MCG/ML VIAL | Brand Single Source | 7 | 10 | 5 | 7 | 8 | 10 | 6 | 17 | 11 | 14 | 14 | 13 | 9 | 15 | 11 | 21 | 16 | 12 | 14 | 11 | 17 | 9 | 9 | 11 | 277 |
| filgrastim 300MCG/0.5 SYRINGE | Brand Single Source | 6 | 17 | 14 | 13 | 9 | 11 | 9 | 18 | 11 | 16 | 8 | 15 | 7 | 15 | 8 | 26 | 4 | 30 | 13 | 23 | 6 | 16 | 11 | 10 | 316 |
| filgrastim 480MCG/0.8 SYRINGE | Brand Single Source | 14 | 14 | 12 | 16 | 17 | 9 | 6 | 18 | 12 | 8 | 7 | 13 | 9 | 19 | 9 | 10 | 7 | 14 | 6 | 11 | 6 | 17 | 4 | 22 | 280 |
| filgrastim 480MCG/1.6 VIAL | Brand Single Source | 6 | 2 | 3 | 3 | 1 | 2 | 1 | 3 | 1 | 4 | 2 | 3 | 1 | 1 | 2 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 44 | ||
| fingolimod HCl 0.5 MG CAPSULE | Brand Single Source | 224 | 50 | 219 | 41 | 220 | 36 | 235 | 37 | 244 | 36 | 216 | 33 | 217 | 29 | 247 | 36 | 190 | 31 | 245 | 33 | 235 | 25 | 206 | 32 | 3,117 |
| glatiramer acetate 20 MG/ML SYRINGE | Brand Originator | 2 | 3 | 5 | 4 | 4 | 2 | 4 | 4 | 3 | 3 | 2 | 3 | 9 | 4 | 3 | 6 | 5 | 3 | 3 | 5 | 6 | 4 | 3 | 5 | 95 |
| glatiramer acetate 20 MG/ML SYRINGE | Generic | 40 | 17 | 46 | 15 | 46 | 21 | 47 | 19 | 34 | 22 | 44 | 17 | 42 | 13 | 39 | 15 | 33 | 10 | 45 | 13 | 39 | 10 | 35 | 9 | 671 |
| glatiramer acetate 40 MG/ML SYRINGE | Brand Originator | 347 | 31 | 305 | 26 | 315 | 22 | 104 | 27 | 81 | 25 | 77 | 28 | 83 | 31 | 69 | 20 | 75 | 21 | 83 | 23 | 66 | 20 | 62 | 17 | 1,958 |
| glatiramer acetate 40 MG/ML SYRINGE | Generic | 1 | 23 | 1 | 19 | 1 | 19 | 175 | 18 | 232 | 22 | 215 | 34 | 219 | 32 | 227 | 35 | 211 | 38 | 255 | 38 | 227 | 36 | 215 | 34 | 2,327 |
| golimumab 100 MG/ML PEN INJCTR | Brand Single Source | 38 | 3 | 26 | 38 | 1 | 34 | 2 | 36 | 29 | 2 | 39 | 1 | 28 | 3 | 33 | 3 | 37 | 3 | 29 | 2 | 27 | 1 | 415 | ||
| golimumab 100 MG/ML SYRINGE | Brand Single Source | 5 | 1 | 4 | 2 | 2 | 3 | 2 | 1 | 1 | 4 | 3 | 2 | 30 | ||||||||||||
| golimumab 50MG/0.5ML PEN INJCTR | Brand Single Source | 168 | 16 | 134 | 13 | 159 | 12 | 157 | 15 | 166 | 14 | 164 | 11 | 164 | 14 | 160 | 12 | 137 | 10 | 141 | 10 | 164 | 11 | 132 | 10 | 1,994 |
| golimumab 50MG/0.5ML SYRINGE | Brand Single Source | 23 | 4 | 25 | 4 | 25 | 8 | 25 | 5 | 16 | 5 | 21 | 2 | 19 | 2 | 20 | 3 | 20 | 6 | 19 | 3 | 18 | 3 | 18 | 5 | 299 |
| imatinib mesylate 100 MG TABLET | Brand Originator | 3 | 3 | 3 | 3 | 3 | 1 | 2 | 1 | 3 | 4 | 3 | 5 | 3 | 2 | 39 | ||||||||||
| imatinib mesylate 100 MG TABLET | Generic | 107 | 25 | 97 | 25 | 101 | 27 | 125 | 24 | 120 | 23 | 115 | 27 | 113 | 30 | 106 | 29 | 103 | 25 | 114 | 37 | 108 | 35 | 109 | 25 | 1,650 |
| imatinib mesylate 400 MG TABLET | Brand Originator | 14 | 7 | 10 | 5 | 12 | 4 | 13 | 7 | 13 | 6 | 10 | 5 | 9 | 3 | 9 | 5 | 8 | 4 | 9 | 5 | 8 | 5 | 11 | 5 | 187 |
| imatinib mesylate 400 MG TABLET | Generic | 309 | 72 | 279 | 72 | 288 | 73 | 302 | 75 | 312 | 66 | 291 | 60 | 292 | 62 | 301 | 60 | 289 | 55 | 307 | 57 | 283 | 52 | 297 | 56 | 4,310 |
| interferon alfa-2b,recomb. 10MM UNIT VIAL | Brand Single Source | 2 | 1 | 1 | 1 | 1 | 1 | 7 | ||||||||||||||||||
| interferon alfa-2b,recomb. 10MM/ML VIAL | Brand Single Source | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 16 | ||||||||||
| interferon alfa-2b,recomb. 18MM UNIT VIAL | Brand Single Source | 1 | 1 | 1 | 3 | |||||||||||||||||||||
| interferon alfa-2b,recomb. 50MM UNIT VIAL | Brand Single Source | 2 | 2 | |||||||||||||||||||||||
| interferon alfa-2b,recomb. 6MMUNIT/ML VIAL | Brand Single Source | 3 | 4 | 3 | 4 | 2 | 5 | 2 | 4 | 2 | 2 | 3 | 2 | 3 | 3 | 2 | 1 | 1 | 3 | 4 | 3 | 3 | 3 | 4 | 2 | 68 |
| interferon beta-1a 30MCG/.5ML PEN IJ KIT | Brand Single Source | 75 | 22 | 72 | 17 | 75 | 20 | 67 | 18 | 85 | 19 | 53 | 18 | 71 | 14 | 85 | 12 | 55 | 13 | 74 | 17 | 70 | 14 | 65 | 14 | 1,045 |
| interferon beta-1a 30MCG/.5ML SYRINGEKIT | Brand Single Source | 63 | 6 | 68 | 8 | 50 | 13 | 63 | 13 | 70 | 13 | 56 | 12 | 65 | 9 | 58 | 15 | 50 | 7 | 66 | 11 | 61 | 7 | 47 | 7 | 838 |
| interferon beta-1a/albumin 22MCG/.5ML PEN INJCTR | Brand Single Source | 4 | 1 | 2 | 1 | 2 | 1 | 2 | 3 | 3 | 19 | |||||||||||||||
| interferon beta-1a/albumin 22MCG/.5ML SYRINGE | Brand Single Source | 2 | 1 | 3 | 1 | 4 | 1 | 3 | 1 | 5 | 1 | 6 | 1 | 3 | 1 | 6 | 2 | 1 | 2 | 4 | 1 | 4 | 2 | 3 | 1 | 59 |
| interferon beta-1a/albumin 30 MCG KIT | Brand Single Source | 4 | 1 | 4 | 2 | 3 | 1 | 4 | 3 | 2 | 2 | 7 | 2 | 3 | 1 | 3 | 2 | 5 | 2 | 1 | 2 | 4 | 4 | 1 | 1 | 64 |
| interferon beta-1a/albumin 44MCG/.5ML PEN INJCTR | Brand Single Source | 32 | 9 | 30 | 5 | 38 | 4 | 21 | 5 | 27 | 4 | 37 | 2 | 24 | 1 | 28 | 4 | 27 | 3 | 26 | 1 | 30 | 3 | 26 | 1 | 388 |
| interferon beta-1a/albumin 44MCG/.5ML SYRINGE | Brand Single Source | 45 | 7 | 40 | 8 | 43 | 8 | 43 | 8 | 51 | 8 | 46 | 6 | 46 | 7 | 38 | 4 | 40 | 6 | 40 | 9 | 45 | 7 | 38 | 2 | 595 |
| interferon beta-1a/albumin 8.8-22(6) PEN INJCTR | Brand Single Source | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 3 | 2 | 1 | 24 | |||||||||
| interferon beta-1a/albumin 8.8-22(6) SYRINGE | Brand Single Source | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 9 | |||||||||||||||||
| interferon beta-1b 0.3 MG KIT | Brand Originator | 37 | 6 | 41 | 8 | 44 | 10 | 41 | 9 | 51 | 9 | 34 | 7 | 35 | 6 | 58 | 10 | 33 | 9 | 40 | 5 | 48 | 4 | 37 | 4 | 586 |
| interferon gamma-1b,recomb. 100MCG/0.5 VIAL | Brand Single Source | 1 | 5 | 4 | 2 | 5 | 2 | 4 | 3 | 3 | 3 | 1 | 3 | 36 | ||||||||||||
| ledipasvir/sofosbuvir 90MG-400MG TABLET | Brand Originator | 83 | 13 | 85 | 12 | 91 | 18 | 83 | 21 | 79 | 18 | 81 | 17 | 66 | 17 | 53 | 17 | 42 | 19 | 48 | 12 | 60 | 15 | 69 | 10 | 1,029 |
| leuprolide acetate 1 MG/0.2ML KIT | Generic | 16 | 70 | 9 | 73 | 10 | 91 | 8 | 92 | 12 | 140 | 22 | 89 | 13 | 86 | 8 | 85 | 13 | 77 | 15 | 107 | 11 | 95 | 14 | 105 | 1,261 |
| leuprolide acetate 11.25 MG KIT | Brand Single Source | 2 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 3 | 2 | 3 | 1 | 24 | |||||||||
| leuprolide acetate 11.25 MG SYRINGEKIT | Brand Single Source | 39 | 15 | 34 | 9 | 44 | 12 | 44 | 10 | 30 | 13 | 43 | 13 | 38 | 11 | 46 | 15 | 29 | 10 | 36 | 9 | 34 | 8 | 30 | 9 | 581 |
| leuprolide acetate 15 MG KIT | Brand Single Source | 6 | 1 | 4 | 3 | 1 | 6 | 1 | 1 | 4 | 1 | 2 | 2 | 5 | 2 | 1 | 3 | 4 | 1 | 4 | 1 | 53 | ||||
| leuprolide acetate 22.5 MG SYRINGE | Brand Single Source | 2 | 3 | 3 | 5 | 4 | 2 | 2 | 6 | 2 | 2 | 6 | 1 | 4 | 1 | 5 | 1 | 4 | 5 | 4 | 62 | |||||
| leuprolide acetate 22.5 MG SYRINGEKIT | Brand Single Source | 10 | 8 | 5 | 6 | 10 | 6 | 14 | 3 | 9 | 10 | 10 | 6 | 14 | 6 | 11 | 7 | 10 | 4 | 16 | 5 | 16 | 3 | 10 | 6 | 205 |
| leuprolide acetate 3.75 MG SYRINGEKIT | Brand Single Source | 43 | 24 | 46 | 26 | 37 | 32 | 41 | 33 | 46 | 27 | 53 | 22 | 48 | 25 | 44 | 28 | 46 | 21 | 61 | 27 | 48 | 25 | 44 | 18 | 865 |
| leuprolide acetate 30 MG SYRINGE | Brand Single Source | 2 | 1 | 1 | 1 | 1 | 1 | 7 | ||||||||||||||||||
| leuprolide acetate 30 MG SYRINGEKIT | Brand Single Source | 23 | 3 | 25 | 5 | 25 | 4 | 30 | 4 | 22 | 4 | 24 | 2 | 30 | 6 | 30 | 3 | 21 | 4 | 32 | 6 | 30 | 4 | 20 | 3 | 360 |
| leuprolide acetate 45 MG SYRINGE | Brand Single Source | 1 | 1 | 4 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 18 | ||||||||||||
| leuprolide acetate 45 MG SYRINGEKIT | Brand Single Source | 8 | 3 | 3 | 7 | 4 | 2 | 1 | 1 | 7 | 2 | 4 | 6 | 4 | 1 | 6 | 1 | 1 | 5 | 1 | 67 | |||||
| leuprolide acetate 7.5 MG KIT | Brand Single Source | 1 | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 18 | |||||||||||
| leuprolide acetate 7.5 MG SYRINGE | Brand Single Source | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 2 | 11 | ||||||||||||||||
| leuprolide acetate 7.5 MG SYRINGEKIT | Brand Single Source | 4 | 3 | 4 | 5 | 5 | 3 | 6 | 2 | 3 | 1 | 2 | 1 | 4 | 1 | 2 | 1 | 5 | 2 | 2 | 1 | 2 | 4 | 6 | 3 | 72 |
| octreotide acetate 100 MCG/ML AMPUL | Brand Originator | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 17 | ||||||||||||
| octreotide acetate 100 MCG/ML SYRINGE | Brand Single Source | 2 | 4 | 4 | 4 | 7 | 3 | 2 | 3 | 3 | 3 | 7 | 3 | 6 | 1 | 9 | 1 | 5 | 1 | 8 | 3 | 1 | 9 | 1 | 90 | |
| octreotide acetate 100 MCG/ML VIAL | Generic | 4 | 10 | 5 | 8 | 3 | 8 | 3 | 15 | 1 | 17 | 1 | 29 | 2 | 8 | 4 | 10 | 2 | 11 | 3 | 10 | 3 | 10 | 3 | 5 | 175 |
| octreotide acetate 1000MCG/ML VIAL | Brand Originator | 10 | 1 | 5 | 6 | 4 | 1 | 5 | 7 | 1 | 1 | 41 | ||||||||||||||
| octreotide acetate 1000MCG/ML VIAL | Generic | 3 | 1 | 1 | 1 | 9 | 1 | 5 | 4 | 1 | 10 | 1 | 6 | 2 | 7 | 1 | 53 | |||||||||
| octreotide acetate 200 MCG/ML VIAL | Brand Originator | 7 | 3 | 10 | ||||||||||||||||||||||
| octreotide acetate 200 MCG/ML VIAL | Generic | 1 | 3 | 3 | 2 | 2 | 5 | 6 | 1 | 9 | 1 | 3 | 2 | 2 | 3 | 4 | 5 | 3 | 2 | 6 | 3 | 3 | 1 | 4 | 3 | 77 |
| octreotide acetate 50 MCG/ML AMPUL | Brand Originator | 2 | 1 | 1 | 1 | 5 | ||||||||||||||||||||
| octreotide acetate 50 MCG/ML SYRINGE | Brand Single Source | 3 | 2 | 3 | 2 | 6 | 2 | 5 | 1 | 1 | 1 | 6 | 1 | 5 | 4 | 5 | 1 | 4 | 2 | 3 | 3 | 3 | 63 | |||
| octreotide acetate 50 MCG/ML VIAL | Generic | 1 | 3 | 1 | 3 | 5 | 5 | 8 | 4 | 4 | 4 | 6 | 9 | 53 | ||||||||||||
| octreotide acetate 500 MCG/ML SYRINGE | Brand Single Source | 1 | 1 | 1 | 1 | 4 | ||||||||||||||||||||
| octreotide acetate 500 MCG/ML VIAL | Generic | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 9 | |||||||||||||||||
| pazopanib HCl 200 MG TABLET | Brand Single Source | 97 | 24 | 94 | 16 | 94 | 21 | 96 | 18 | 100 | 17 | 93 | 18 | 113 | 21 | 95 | 22 | 91 | 21 | 99 | 19 | 97 | 23 | 80 | 19 | 1,388 |
| pegfilgrastim 6 MG/0.6ML SYR W/ INJ | Brand Single Source | 2 | 6 | 5 | 8 | 3 | 21 | 2 | 11 | 2 | 14 | 4 | 10 | 3 | 15 | 5 | 10 | 1 | 8 | 1 | 4 | 3 | 18 | 3 | 9 | 168 |
| pegfilgrastim 6 MG/0.6ML SYRINGE | Brand Single Source | 36 | 29 | 31 | 25 | 35 | 30 | 41 | 26 | 33 | 21 | 21 | 34 | 23 | 35 | 33 | 36 | 28 | 30 | 30 | 23 | 32 | 26 | 26 | 20 | 704 |
| peginterferon alfa-2a 135MCG/0.5 PEN INJCTR | Brand Single Source | 1 | 1 | |||||||||||||||||||||||
| peginterferon alfa-2a 180MCG/0.5 PEN INJCTR | Brand Single Source | 1 | 1 | 1 | 3 | |||||||||||||||||||||
| peginterferon alfa-2a 180MCG/0.5 SYRINGE | Brand Single Source | 1 | 1 | 2 | 1 | 1 | 1 | 7 | ||||||||||||||||||
| peginterferon alfa-2a 180MCG/ML VIAL | Brand Single Source | 2 | 11 | 2 | 5 | 1 | 2 | 2 | 7 | 2 | 3 | 1 | 9 | 4 | 2 | 2 | 3 | 9 | 2 | 2 | 3 | 7 | 2 | 83 | ||
| peginterferon alfa-2b 300 MCG KIT | Brand Single Source | 1 | 1 | |||||||||||||||||||||||
| ribavirin 200 MG CAPSULE | Generic | 3 | 2 | 4 | 3 | 3 | 1 | 1 | 3 | 20 | ||||||||||||||||
| ribavirin 200 MG TABLET | Generic | 2 | 8 | 3 | 4 | 2 | 9 | 2 | 2 | 3 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 4 | 4 | 52 | ||||||
| ribavirin 40 MG/ML SOLUTION | Brand Single Source | 1 | 1 | 2 | ||||||||||||||||||||||
| sargramostim 250 MCG VIAL | Brand Single Source | 1 | 4 | 1 | 2 | 1 | 2 | 1 | 1 | 2 | 1 | 3 | 2 | 1 | 4 | 1 | 3 | 1 | 31 | |||||||
| sofosbuvir 400 MG TABLET | Brand Single Source | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 10 | ||||||||||||||||
| sofosbuvir/velpatasvir 400-100 MG TABLET | Brand Originator | 23 | 15 | 20 | 8 | 24 | 9 | 25 | 6 | 26 | 8 | 26 | 3 | 16 | 3 | 14 | 2 | 14 | 3 | 25 | 4 | 19 | 6 | 18 | 3 | 320 |
| sorafenib tosylate 200 MG TABLET | Brand Single Source | 49 | 7 | 50 | 4 | 41 | 9 | 48 | 5 | 50 | 10 | 47 | 8 | 55 | 6 | 43 | 7 | 46 | 3 | 39 | 9 | 33 | 4 | 42 | 3 | 618 |
| sunitinib malate 12.5 MG CAPSULE | Brand Single Source | 13 | 8 | 7 | 10 | 1 | 8 | 9 | 2 | 9 | 2 | 7 | 3 | 5 | 2 | 7 | 2 | 6 | 1 | 3 | 3 | 108 | ||||
| sunitinib malate 25 MG CAPSULE | Brand Single Source | 27 | 5 | 25 | 2 | 28 | 2 | 24 | 1 | 20 | 1 | 20 | 19 | 4 | 23 | 1 | 11 | 1 | 20 | 1 | 21 | 2 | 19 | 1 | 278 | |
| sunitinib malate 37.5 MG CAPSULE | Brand Single Source | 23 | 8 | 17 | 9 | 24 | 8 | 23 | 3 | 23 | 4 | 16 | 3 | 24 | 5 | 21 | 4 | 14 | 4 | 19 | 4 | 15 | 7 | 18 | 6 | 302 |
| sunitinib malate 50 MG CAPSULE | Brand Single Source | 27 | 9 | 18 | 2 | 18 | 7 | 17 | 7 | 17 | 3 | 18 | 1 | 20 | 13 | 4 | 12 | 3 | 20 | 7 | 14 | 6 | 20 | 7 | 270 | |
| teriflunomide 14 MG TABLET | Brand Single Source | 214 | 17 | 164 | 18 | 229 | 21 | 192 | 20 | 202 | 22 | 202 | 22 | 211 | 20 | 209 | 21 | 200 | 21 | 225 | 27 | 206 | 18 | 200 | 25 | 2,706 |
| teriflunomide 7 MG TABLET | Brand Single Source | 18 | 5 | 22 | 3 | 20 | 4 | 20 | 2 | 26 | 3 | 15 | 2 | 24 | 3 | 26 | 2 | 20 | 1 | 30 | 1 | 25 | 4 | 15 | 3 | 294 |
| teriparatide 20MCG/DOSE PEN INJCTR | Brand Single Source | 864 | 161 | 679 | 177 | 721 | 175 | 772 | 213 | 727 | 204 | 696 | 179 | 694 | 167 | 754 | 171 | 644 | 149 | 748 | 156 | 704 | 125 | 615 | 130 | 10,625 |
| tocilizumab 162 MG/0.9 SYRINGE | Brand Single Source | 205 | 26 | 162 | 21 | 202 | 19 | 196 | 20 | 202 | 26 | 199 | 31 | 205 | 27 | 200 | 38 | 200 | 36 | 216 | 43 | 206 | 29 | 205 | 31 | 2,745 |
| tofacitinib citrate 10 MG TABLET | Brand Single Source | 1 | 1 | 6 | 2 | 10 | 9 | 13 | 11 | 19 | 14 | 86 | ||||||||||||||
| tofacitinib citrate 5 MG TABLET | Brand Single Source | 374 | 41 | 328 | 34 | 384 | 40 | 333 | 35 | 350 | 35 | 329 | 34 | 370 | 39 | 326 | 36 | 333 | 32 | 319 | 44 | 344 | 35 | 352 | 39 | 4,586 |
| ustekinumab 45MG/0.5ML SYRINGE | Brand Single Source | 198 | 26 | 196 | 15 | 171 | 24 | 183 | 34 | 207 | 20 | 205 | 25 | 195 | 16 | 220 | 12 | 190 | 12 | 189 | 31 | 207 | 17 | 187 | 14 | 2,594 |
| ustekinumab 90 MG/ML SYRINGE | Brand Single Source | 274 | 32 | 210 | 20 | 248 | 27 | 242 | 23 | 286 | 23 | 257 | 28 | 252 | 26 | 287 | 23 | 271 | 29 | 293 | 41 | 295 | 24 | 296 | 26 | 3,533 |
| Grand Total | 12,928 | 2,637 | 11,173 | 2,366 | 12,205 | 2,570 | 12,014 | 2,557 | 12,383 | 2,671 | 11,839 | 2,427 | 12,224 | 2,457 | 12,475 | 2,567 | 11,336 | 2,318 | 12,678 | 2,657 | 11,972 | 2,412 | 11,475 | 2,340 | 174,681 |
Specialty Drug Listing 2017
| PRODUCT_SERVICE_ID | LABEL_TXT | DRUG_LIST_ID | DRUG_LIST_NME |
| 00053765601 | MONOCLATE-P 250 UNIT KIT | 164348 | DOD-Specialty Drug list |
| 00053765602 | MONOCLATE-P 500AHFU KIT | 164348 | DOD-Specialty Drug list |
| 62756052926 | DESMOPRESSIN 40 MCG/10 ML VIAL | 164348 | DOD-Specialty Drug list |
| 55566504001 | DESMOPRESSIN AC 4 MCG/ML VIAL | 164348 | DOD-Specialty Drug list |
| 69918090110 | DESMOPRESSIN AC 4 MCG/ML VIAL | 164348 | DOD-Specialty Drug list |
| 62756052940 | DESMOPRESSIN 40 MCG/10 ML VIAL | 164348 | DOD-Specialty Drug list |
| 55566230000 | DDAVP 4 MCG/ML VIAL | 164348 | DOD-Specialty Drug list |
| 00703505101 | DESMOPRESSIN AC 4 MCG/ML VIAL | 164348 | DOD-Specialty Drug list |
| 00075245153 | DDAVP 4 MCG/ML VIAL | 164348 | DOD-Specialty Drug list |
| 00703505401 | DESMOPRESSIN AC 4 MCG/ML VIAL | 164348 | DOD-Specialty Drug list |
| 00703505103 | DESMOPRESSIN AC 4 MCG/ML VIAL | 164348 | DOD-Specialty Drug list |
| 55566503001 | DESMOPRESSIN AC 4 MCG/ML AMPUL | 164348 | DOD-Specialty Drug list |
| 69918089901 | DESMOPRESSIN AC 4 MCG/ML AMPUL | 164348 | DOD-Specialty Drug list |
| 69918089910 | DESMOPRESSIN AC 4 MCG/ML AMPUL | 164348 | DOD-Specialty Drug list |
| 00075245101 | DDAVP 4 MCG/ML AMPUL | 164348 | DOD-Specialty Drug list |
| 00409226501 | DESMOPRESSIN AC 4 MCG/ML AMPUL | 164348 | DOD-Specialty Drug list |
| 55566220000 | DDAVP 4 MCG/ML AMPUL | 164348 | DOD-Specialty Drug list |
| 00074228203 | LUPRON DEPOT-PED 11.25 MG KIT | 164348 | DOD-Specialty Drug list |
| 00074210803 | LUPRON DEPOT-PED 7.5 MG KIT | 164348 | DOD-Specialty Drug list |
| 00074244003 | LUPRON DEPOT-PED 15 MG KIT | 164348 | DOD-Specialty Drug list |
| 55513054610 | NEUPOGEN 480 MCG/1.6 ML VIAL | 164348 | DOD-Specialty Drug list |
| 55513054601 | NEUPOGEN 480 MCG/1.6 ML VIAL | 164348 | DOD-Specialty Drug list |
| 55513020910 | NEUPOGEN 480 MCG/0.8 ML SYR | 164348 | DOD-Specialty Drug list |
| 55513020991 | NEUPOGEN 480 MCG/0.8 ML SYR | 164348 | DOD-Specialty Drug list |
| 55513020901 | NEUPOGEN 480 MCG/0.8 ML SYR | 164348 | DOD-Specialty Drug list |
| 55513092410 | NEUPOGEN 300 MCG/0.5 ML SYR | 164348 | DOD-Specialty Drug list |
| 55513092491 | NEUPOGEN 300 MCG/0.5 ML SYR | 164348 | DOD-Specialty Drug list |
| 55513092401 | NEUPOGEN 300 MCG/0.5 ML SYR | 164348 | DOD-Specialty Drug list |
| 55513000204 | ARANESP 25 MCG/ML VIAL | 164348 | DOD-Specialty Drug list |
| 55513000201 | ARANESP 25 MCG/ML VIAL | 164348 | DOD-Specialty Drug list |
| 55513000304 | ARANESP 40 MCG/ML VIAL | 164348 | DOD-Specialty Drug list |
| 55513000301 | ARANESP 40 MCG/ML VIAL | 164348 | DOD-Specialty Drug list |
| 55513000404 | ARANESP 60 MCG/ML VIAL | 164348 | DOD-Specialty Drug list |
| 55513000401 | ARANESP 60 MCG/ML VIAL | 164348 | DOD-Specialty Drug list |
| 55513000504 | ARANESP 100 MCG/ML VIAL | 164348 | DOD-Specialty Drug list |
| 55513000501 | ARANESP 100 MCG/ML VIAL | 164348 | DOD-Specialty Drug list |
| 55513000601 | ARANESP 200 MCG/ML VIAL | 164348 | DOD-Specialty Drug list |
| 65862029070 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 65862029056 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 66435010118 | RIBASPHERE 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 65862029084 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 65862029042 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 65862029018 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 66435010142 | RIBASPHERE 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 68382026007 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 68382026004 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 68382026012 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 68382026009 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 68084017965 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 66435010170 | RIBASPHERE 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 66435010156 | RIBASPHERE 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 68084017911 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 66435010184 | RIBASPHERE 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 00781204316 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 00781204304 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 00085135105 | REBETOL 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 00085119403 | REBETOL 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 00085138507 | REBETOL 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 00781204342 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 54738095384 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 54738095370 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 54738095356 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 00781204367 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 54738095342 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
| 54738095318 | RIBAVIRIN 200 MG CAPSULE | 164348 | DOD-Specialty Drug list |
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it. Updated .